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The Machine Age man still possesses a Stone Age stomach; sometimes the job of merely coping with today's
environmental stress may prove too much. For some
(the "spasm reactors" in your practice), tension, anxiety and worry may find expression through the voice of
gastrointestinal or other smooth muscle spasm. To treat
these patients with antispasmodics alone is often to
miss the point of origin of their disturbance; to rely
solely on tranquilizers often proves discouragingly slow
or ineffective in relieving spasm and pain.

To quiet and quell Donnatal can promptly and effectively quell the spasm and quiet the tensions that trigger
it. Prescribed by more physicians than any other antispasmodic-sedative, Donnatal continues to provide the
classic answer.

The "Donnatal Effect" The characteristic, over-all
effect of Donnatal has been observed in many thousands
of children and adults, clearly establishing its value as
a versatile sedative-antispasmodic. Outstanding in effectiveness, safety, economy, uniformity of composition
and dosage convenience, Donnatal continues to be desired and prescribed by a majority of physicians.
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In a multiplicity of indications Particularly useful
when anxiety and tension accompany, aggravate or account for smooth muscle spasm, Donnatal is indicated
for the symptomatic relief of recurring, persistent or
chronic visceral spasm. More than two dozen distinct
and separate indications for Donnatal are listed on page
97 4 in the current PDR.
Brief summary Blurring of vision, dry mouth, difficult urination, and flushing or dryness of the skin may
occur on higher dosage levels, rarely on usual dosage.
Administer with caution to patients with incipient glaucoma or urinary bladder neck obstruction. Contraindicated in acute glaucoma, advanced renal or hepatic
disease or a hypersensitivity to any of the ingredients • .
each tablet, capsule or
each
5cc. of elixir (23 % alcohol)
Extentab®
hyoscyamine sulfate ................ 0.1037 mg.
0.3111 mg.
atropine sulfate ........................ 0.0194 mg,
0.0582 mg.
hyoscine hydrobromide ............ 0.0065 mg.
0.0195 mg.
phenobarbital .................... ( 14 gr.) 16.2 mg.
( % gr.) 48.6 mg.
(warning: may be habit forming)
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Symposium on Intracellular pH,

PC02 and P02
ERNST G. HUF, M.D., Ph.D., Guest Editor

INTRODUCTORY REMARKS
JOHN L. PATTERSON, JR., M.D., Chairman

It is a pleasure to welcome the three authorities
who will carry the major load of presentations in our
symposium today. They are Dr. Frans !Obsis of Duke
University School of Medicine, Dr. Eugene Robin
of The University of Pittsburgh School of Medicine, and Dr. Norman Carter of The University of
Texas Southwestern Medical School. We are also
grateful for the presence of Dr. Lµtz Kiesow of the
Naval Medical Research Institute, Bethesda, Maryland.
Dr. Kiesow will assist in the discussions to be held
after each major presentation. Each of these men is an
international authority in his field, and we are more
than fortunate to have this group with us today.
The topics for this symposium were chosen almost
as a matter of necessity. In recent years, some of the
best basic and applied research in the physiology of
the circulation and respiration has been concerned
with the physiological and biochemical roles in the
body economy of the tensions of oxygen and carbon
dioxide, and of the hydrogen ion concentration or
activity. In our own group, we find ourselves more
and more frequently forced into consideration or
speculation of the probable behavior of the "tissue"
or intracellular tensions of these gases and of the pH
in our attempts to explain experimental phenomena.
We feel safe in predicting increasing emphasis on the
intracellular values of these three major variables in
the next few years, and we have felt the urgent need
to take stock now of the best present information. Our
speakers will define the variables under consideration
and discuss methods for their measurement and their
physiologic and bioch.emical roles in the cellular economy. They have been told that they are free to
emphasize those aspects of the subject of greatest
interest to them.
Again, I wish to welcome each of the speakers and
present the first of them, Dr. Frans Jobsis, whose topic
will be "Oxygen Tension: Direct Observations on the
Critical Level for the Brain."
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Oxygen Tension: Direct Observations
on the Critical Level for the Brain *t
FRANS F. JOBSIS

Department of Physiology and Pharmacology, Duke University
School of Medicine, Durham, North Carolina 27706

In this lecture I want to address
myself to the questions: What is the
lowest oxygen tension compatible
with adequate function, and what
are the factors that set this limit?
Much of the background to the
material presented here has been
reviewed extensively in the not too
distant past (JObsis '64), and I
will take the liberty of letting that
article provide most of the detailed
justification of my remarks today.

I. Mechanisms of Oxygen
Utilization
In mammals there are three
mechanisms for the utilization of
dissolved oxygen. First, I will list
these, and then I will emphasize the
last one of these, since it accounts
for the major part, by far, of the
oxygen uptake in the body. These
three are:
A. Oxygen trans/erases
for which the generalized reaction can be written
A+ 0 2 ~ A02
in which A is a substrate that
accepts two separate oxygen atoms;
B. Mixed function oxidases
with the reaction
AH+ 2e- +

o.~ AOH

+

o=

(~H20)

where the last notation signifies the rapid final step of water
production from o= and 2H+ ions;

* Supported in part by Grant NB
06729 from the National Institutes of
Health.
tPresented at the Symposium on
Intracellular pH, PCO., and PO,, September 29, 1967, Medical College of
Virginia, Richmond.
MCV QUARTERLY 3(4): 169-188, 1967

C. Electron transfer oxidases
catalyzing the reaction
4e- + 02 ~20= (~2H,O)
Numbers one and two are mainly
active in the catalytic oxidation of
amino acids and of some steroids
and account at most for 1 % of
the total 02 consumption in mammals. They are, therefore, of very
little importance to us in this
symposium.
The enzyme systems catalyzing
the last category can be subdivided
into, firstly, autoxidative flavoproteins and, secondly, the respiratory
chain.
1. The oxidation of autoxidative flavoproteins can be written
flavinH, + 0 2 ~ flavin + H.O.
The hydrogen peroxide formed is
removed by the action of catalase.
These reactions may account for
about 10% of the total oxygen uptake in the body. We are not too
sure where this uptake takes place
or even what subdivision of the cell
is the site of this oxygen consumption. One of the few known variables affecting this reaction is acclimation. Russian workers have
shown that, during hibernation,
the fraction mediated by the autoxidative flavoproteins goes from
10% to approximately 25 % (Skulachev, 1962). Another important
fact is that no mechanism has been
found by which energy conservation takes place in this reaction.
More specifically, no high energy
phosphate production has been
found associated w ith this reaction.
2. The respiratory chain accounts for all the rest of the oxygen
taken up by the tissues. This is the
mitochondrial contribution to overall oxidative metabolism. A system

of redox couples catalyzes the transfer of reducing equivalents from the
substrates to oxygen and results in
the formation of water. This is
shown in Figure 1 together with
some of the inhibitors and side
reactions of the respiratory chain.
In the respiratory chain three locations, identified by asterisks in
the above scheme, contribute to the
overall process by being loci for
the conservation of energy in the
form of high-energy phosphate
bonds (-P) that are transferred to
adenosine diphosphate (ADP) to
form adenosine triphosphate
(ATP). The reaction, which is referred to as oxidative phosphorylation, is obligatorily coupled to the
electron transfer steps in the chain.
This coupling produces an effective
control mechanism for the rate of
oxygen uptake. If no ADP is available, no oxidative phosphorylation
can take place, and electron transport is slowed down dramatically.
This gives rise to the difference in
rates of O, consumption during
rest and during strenuous exercise.
Failure of oxidative phosphorylation to take place is the main harm
associated with anoxia. The respiratory chain plus its side reaction,
oxidative phosphorylation, is, therefore, the reaction system that must
be understood for any discussion
of critical O, levels. I would like to
discuss these processes now.
Starting at the substrate side of
the respiratory chain, we enter
with certain substrates and their
dehydrogenases which will reduce
NAD+ to form NADH (nicotinamide-adenine di nucleotide). [The
old-fashioned name was DNP, and
many people still refer to it as
DPN+ and DPNH]. NADH is able
169
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to reduce flavoproteins and, then,
from there, follow a set of redox
couples, each one oxidizing its predecessor by electron transfer and being oxidized by the next one until O,
is reached. This is a set of cytochromes identified by letters, i.e.,
cytochrome b, cytochrome c,, cytochrome c, cytochrome a and cytochrome a,. Potential differences between the numbers of the respiratory chain are neatly arranged along
the line so that electron transfer
proceeds naturally toward o•.
At three locations, the potential
energy of the overall reactionwhich in the end is really the reaction of hydrogen in the substrate
with oxygen to form H.O- this
potential energy of burning up the
substrate is saved. In these three
spots, reactions take place resulting
in the formation of ATP from ADP
and inorganic phosphate. There are
three of these sites, and three P
moieties are formed per oxygen
atom. However, there are certain
substrates, such as succinate, that
are oxidized without benefit of
NAD , and their oxidation only
yields 2,_, P, since the site between
NAD and flavoprotein is Jost.
These two functions, electron
transfer and high energy phosphate
production, are very tightly coupled.
They are obligatorily linked. Without the one the other does not take

ma late

place, unless something is amiss.
This brings with it some very important corollaries. For instance,
if there is not enough ADP near the
mitochondria, oxygen uptake comes
to a halt, because partial blocks
occur at three steps. This is referred
to as respiratory control. In the
same vein, the absence of electron
acceptor (02) results in stoppage of
electron transfer and, therefore, no
further oxidative phosphorylation
takes place. This is the fatal outcome of asphyxiation.
II. Main Phases of Foodstuff
Degradation
After this very rapid introduction, I would like to discuss some of
these points more quantitatively
and emphasize the methods that
are available for the study of the
respiratory chain. I think this is
very important, and I am glad that
Professor Patterson emphasized
your interest in methods. Without
an understanding of the methods,
we really don't have a thorough
understanding of the reliability of
a scientific assertion, especially at
the level of complexity that we
meet in biology. Therefore, I will
emphasize the methods as we go
along.
Starting then on the substrate
side, Table 1 summarizes the re-

Electron transfer inhibitors

NADH

( 2 )~~',',~,~~

a-ketogiutarate
p-OH butyrate

, / l3),

Glutamate
(

"'~',

Antimycin A /
urethane

~/

a-glycerophosphate
succinate
etc.
Substrates

(2)

I

fp

~(2)
~

~

~
0
cN

BAL

s=

HOQNO

N3
I

etc.
'~
Substrates ~NADH ~ fp ~ cyt.b
(I)
{I)
(!~ ~

*

actions between the ingestion of
food and the form in which it
enters the Krebs cycle. The table is
adapted from Krebs and Kornberg
(1957) and speaks further for itself. What occurs is a rather amazing simplification of a great variety
of compounds. The cell modifies
and simplifies these complex substances into a rather small number
of intermediates. Thus, we end up
with acetyl coenzyme A and a few
other things such as a-ketoglutaryl
and oxaloacetic acid. In the third
phase these three feed into the citric
acid cycle, and there decarboxylation and dehydrogenation take
place. This, of course, is the important step; this is where NADH
is being formed. I always like to
think of decarboxylation as just
getting rid of the carbons. No energetically advantageous steps are involved in it. The carbons can be
looked upon as nothing more than
vehicles for carrying hydrogens
around the citric acid cycle for the
reduction of NAD and fiavoproteins.
In Table 2 I have taken these
same four phases and emphasized
the high energy yield per carbon
atom. It is very straightforward for
carbohydrates: 6.4,_, P per carbon.
It is a bit arbitrary for fats, because they differ so much in chain
length. I have chosen palmitate as

'

:

* cyt . c 1 ~ cyt.c ;.::==:: cyt.a
* ;.::==:: cyt . a~ o,
r=:::=
:

3

0

Fig. 1-The respiratory chain. The asterisks indicate the probable locations of the phosphorylative steps. The dashed lines
illustrate the point of action of inhibitors blocking the transfer of electrons to oxygen. (BAL: British Anti-Lewisite; HOQNO:
a-hydroxy quinoline N-oxime.) (Reprinted with permission from Handbook of Physiology, Ji:ibsis, 1964.)
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TABLE 1
The four main phases of foodstuff degradation
Outline of Chemical Change

Phase

I

carbohydrates

proteins

fats

l

l

l

about 20 amino acids

hexoses

hexoses

II

glycerol

l

lactic
acid

I

j

several
amino acids
(alanine,
serine,
cysteine)

fatty
acids

I

several
amino acids

several
amino acids
(glutamic
acid,
histidine,
prolines,
arginine)

"~"·~.

tyrosine,
6
phenylalanine)

oxaloacetic
acid

oxaloacetic acid

a-ketoglutaric a cid

decarboxylation
and
dehydrogenation

J

I

L

dehydrogenation,
decarboxylation,
deamination and
shortening of the
carbon chain

1

l

l

acetyl coenzyme A

several
amino acids
(aspartic acid;
tyrosine,
phenylalanine)

a-ketoglutaric acid '

acetyl coenzyme A
III

depolymerization

glycerol; fatty acids

_J

pyruvic acid

Primary Reactions

I

·

l

citric acid .cycle
~·

l

l

IV

L

H20 production

flavin-H2

NADH

I

respiratory chain

TABLE 2
Location, products and profits of the four main phases of foodstuff degradation

R educing Equivalents

Phase

Primary

Chemical Change

Waste

Location

~P Yield
Per Carbon Atom

Products

Yield

Destination

CarOOhydrates

Fats
I -

D e polymerization

None

None

D eh ydrogenation,
Cytoplasmic and
d ecarboxylation ,
intramitochondeamination, and
d r ia l
shorte ning of the
carbon chain

NH3 and urea;
small amounts of
C O , and H ,O

Small amounts of
NADH and
flavin-H2

Used in
IV

0. 33

- o.o6

III

Decarboxylation
and d ehydrogena tion

Intramitochondrial
fluid pha se

co,

Large increase in
NADH and
flavin-H2; small
increase in
NADPH

Used in
IV

0.33

0 .50

IV

H20 production

Mitochondria l
membra nes

H20

La rge decrease in
NADH and
flavin-H2

5 .7o

8.oo

I

Extracellular and
cytoplasmic

None

None

--II

I
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an example. The longer the chain,
the higher your net yield, since you
have to pay a standard price in activation no matter how long the
chain. I have not even attempted
to calculate a similar number for
amino acids; they are too dissimilar.
Note that, in the first stage, there
is no yield of high energy phosphates. In the second stage there is
a very small yield, and actually there
is utilization of high energy phosphates in fatty acid metabolism.
There is an extremely small provision by so-called substrate level
phosphorylations in the third phase,
the citric acid cycle level. In the
fourth or final phase, however, the
great bulk of high energy phosphates arises. In other words, the
most important yield derives from
the last phase, and it is mediated by
the respiratory chain.
It is simple enough to measure
these reactions in a vessel, a manometric one if you need to know the
amount 0, consumed. It is more
meaningful, however, to study the
system in the intact, circulated tissue rather than with slices or iso-

lated mitochondria. It is here that
special instrumental methods are
needed. Almost without exception
such methods have been pioneered
since 1946 by Dr. Britton Chance
at the Johnson Foundation, Departments of Biophysics and Physical
Biochemistry of the University of
Pennsylvania.
Ill. Split-Beam
Spectrophotometric Method
The great boon in the study of
the respiratory chain, and actually
the factor upon which the discovery of the cytochromes hinged,
is the fact that each of the members has optical activity: they absorb light at specific wavelengths.
In the 1920's, Professor Keilin first
described the series of components
that is now known as the cytochrome chain (Keilin, 1925). Although he drew some strong inferences regarding its function, he
did not know, at that time, that
energy was being conserved in conjunction with the cytochrome activity. That had to wait until the

Tun9sten or·

f:\ hi9h pressure
\ J HQ arc lamp

=

Synchronized Chart
with linear wovelenoth scale

Optic al

Density

Fig. 2-The split-beam, difference spectrophotometer. The difference in light
intensity emerging from the two sample cells is logarithmically recorded on a
chart directly coupled with the wavelength drive of the monochromator. The
resulting graph is a recording of the difference in optical density at the various
wavelengths. (Reprinted with permission from M ethods in Enzymology,
Chance, 1957.)
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late 1930's. All of his conclusions
were the result of visual spectroscopy. Nowadays we use spectrophotometry to do the same thing.
In this approach one first needs to
determine the identity and the concentration of different components.
For this purpose a special type of
spectrophotometer, the so-called
"split-beam," is used. It is especially
designed for highly light-scattering
preparations such as mitochondria
suspended in a solution or intact
tissue. The instrument is shown in
Figure 2. Starting from the light
source, the beam is diffracted in a
monochromator and is alternately
deflected by means of an oscillating mirror through two cuvettes
placed side by side. One of these is
the sample; the other serves as the
reference. The light emerging from
these two cuvettes is measured by
a photomultiplier. There is a bit
of electronic circuitry concerned
with unscrambling the pulses so
that one can keep track of the light
absorption of the sample as compared with the reference cell. After
subtraction, the difference is recorded logarithmically. This renders the data directly in OD units
which are proportional to concentrations. The monochromator
sweeps through the wavelengths
from about 650 m,u, which is the
dark red, to about 300 mµ. in the
very near UV. The differences in
absorption are recorded on a wavelength scale. Starting with two suspensions of isolated mitochondria,
for example, the first run provides a
base line, since one started out with
equal samples. After an experimental manipulation, for instance
the removal of oxygen, one sweeps
through again, and the difference
between the oxidized and the reduced materials is now recorded.
Figure 3 shows two absolute spectra and their difference spectrum,
using hemoglobin as an example.
The absorption spectrum of hemoglobin in the oxygenated form is
shown by the solid curve, in the
disoxygenated form by the broken
curve. These are absolute spectra;

F. F. JOBSIS

but if one puts a disoxygenated sample of hemoglobin in the sample
cuvette and oxygenated hemoglobin
in the reference cuvette, the resulting curve is a difference spectrum,
as shown in the upper part of Figure 3.

Studies on Mitochondria

The same thing can be done for
the respiratory chain in the mitochondria. Mitochondria are obtained from the cells by grinding
and differential centrifugation. They
are suspended in an appropriate
medium and aliquots are pipetted
into the two cuvettes. The spectrum
in the top of Figure 4 shows the
differences in OD between oxygenated and anoxic mitochondria.
The latter were on the sample side;
the former served as reference. The
location of the peaks identifies the
components; the height of the peaks,
the concentration. Reduced cytochromes and NADH have absorption bands that are sharper and
more intense than those of the
oxidized form . Therefore, the peaks
are in the upward direction. The
cytochromes produce a complex of
beta bands which are rather indefinable and are grouped together.
Note that the large trough at 465
mµ. is related to flavoprotein reduction; in contrast with the cytochromes, the flavoproteins absorb
more strongly in the oxidized form.

spectrum of Figure 4. With some
minor differences it is much the
same as the spectrum of the isolated mitochondria. So it is possible
to make these observations and
measure the concentrations in intact tissues. For a physiologist that
is reality. Now we can use the
level of reduction as an indicator
system. For Professor Keilin it was
the beginning. After his visual observations of the cytochrome bands
in intact cells, he was obliged to
isolate and identify the compounds
giving rise to them. Some thirty

I
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I
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4SO
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I
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I

490
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years later Dr. Chance was able to
quantitate the observation in tissues with his new instrumentation.
Nowadays it is not too difficult to
make identifications and measure
concentrations in most any tissue
that interests you.
Reduction Level of Metabolic
States

Since we now have a method
for following changes in oxidation
and reduction of the members
of the respiratory chain, the ques-
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Studies on Muscle

Since I am a physiologist, I consider it important to show that this
is not a biochemist's artifact; that
it is possible to measure the cytochrome absorption peaks in whole
cells also. One does this by taking
two pieces of tissue, for instance,
two muscles carefully dissected, one
from the left leg and one from the
right leg, and measuring the difference spectrum between the
anoxic sample and the oxygenated
reference. The result is the lower

I

'
I

I

:
\400.r
1

o. ~

jlljlljiijlljlljlljiiji
370

400

430

460

4°!10

520

550

510

jlljl
610

640

'111111)

Fig. 3-Absolute spectra of oxygenated (solid line, bottom) and disoxygenated
hemoglobin (broken line) and their difference spectrum (top).
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tion of their reduction level in
different metabolic states can be
tackled. Not that we are so very interested in the cytochromes per se,
but they serve as indicators of
changes in the rate of oxygen uptake. For example, 0 2 uptake will
be slow when ADP is lacking in a
suspension of mitochondria otherwise supplied with all the needs for
oxidative phosphorylation (i.e., 0 2,
inorganic phosphate and oxidizable
substrates) . Addition of ADP will
then produce a rapid uptake of
oxygen, which will slow down again
when all the ADP has been turned
into ATP. This can be followed
very easily with an oxygen polarograph, an "oxygen electrode." This
is the ideal experiment for determining what happens to the reduction states of the members of the
respiratory chain when oxidative
metabolism changes, as I will show
in just one minute. Concomitantly
with the O., substrate, ADP and
inorganic phosphate will disappear.
A measure of the efficiency of phosphorylation is the well-known P to
0 ratio, i.e., the ratio of the amount
of inorganic phosphate that disappears to the number of oxygen
atoms utilized. For an NADHlinked substrate it is 3; for a flavoprotein substrate it is 2; when the
entire Krebs cycle is operating, we
get an intermediate value, say, 2.5
to 2.7.
Such measurements are possible
with mitochondria in a cuvette, but
not in intact cells. What is possible,
however, is the monitoring of the
optical density changes related to
reduction level changes of the cytochromes. These absorption effects
were first measured in isolated
mitochondria and were found to
be very specific as we do the ADP
addition experiment. For this we
use a slightly different spectrophotometer. The first one I described can only be used for steady
states when we are identifying
components or looking for concentrations. Now we need to follow
changes in absorption over a limited
time span.
174

system is needed, because the suspensions (and the tissues as well)
are turbid. What is more, the light
scattering is greatly affected by all
sorts of metabolic reactions. When
light-scattering changes take place,
they are indistinguishable from absorption changes. Both result in
changes in photomultiplier current,
because light is lost. However, it is
lost equally, at first approximation,
from the reference and measuring
wavelengths. Therefore, changes in
the difference between the two
beams are significant, not the total
signal. Total signal changes 20

IV. Double-Beam
Spectrophotometric Method
For this purpose Dr. Chance developed the so-called "double-beam"
spectrophotometer (Fig. 5). A single light source is used for two
monochromators. One is set for the
wavelength of an absorption peak,
the other at an indifferent wavelength to serve as a reference beam.
The two beams are alternately
switched by a vibrating mirror, proceed through the sample, and the
emerging light is measured by an
end-window photomultiplier. This
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Fig. 4-Difference spectra of the respiratory chain. Sample: reduced by anoxia;
reference: in the presence of oxygen. Upper curve: two aliquots of suspended
mitochondria isolated from rat liver [anoxic (state 5) minus starved (state 2)].
Lower curve: two excised toad sartorius muscles [anoxic (state 5) minus resting
with endogenous substrates (state 1)]. (Reprinted with permission from Handbook of Physiology and J. Gen. Physiol., JObsis, 1963 and 1964.)
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times greater than the true absorption changes can thus be tolerated.

Studies on Mitochondria
If we follow the absorption of
one of these cytochromes as we go
through some of the more obvious
metabolic conditions, we will see a
characteristic pattern emerge (Fig.
6). At 430 - 400 m,u, cytochrome
b is monitored. As the mitochondria
come out of the c~ntrifuge tube and
are put in a cuvette, we start the
trace. Now we add ADP, and a decreasing absorption at 430 m,u compared to 400 m,u, signifies that an
oxidation of cytochrome b takes
place. This is inevitable. Substrates
have not been added . The ADPstimulated, high rate of 0 2 uptake
soon exhausts the endogenous substrate supply of the mitochondria,
and cytochrome b goes fully oxidized. At this point .,B-hydroxybutyrate is added, NAD is reduced:
we see a change towards a higher
level of reduction. A plateau is
maintained for a short while; then
another change occurs. Concomitant biochemical determinations
will show that at this point the ADP
that was added has now been phosphorylated to ATP. Electron transfer slows down, and a more reduced state results because of the
blocking of the respiratory chain
further down, close to oxygen. Reducing equivalents accumulate,
therefore, in cytochrome b. When
oxygen uptake is stimulated again
by a new addition of ADP, cytochrome b returns to the previous,
more oxidized state while ATP is
being formed. After a number of
such cycles, all the oxygen is used
up, and an extremely large change
will indicate that b goes completely
reduced. Very much the same thing
occurs for NADH, as is shown in
the right-hand record of Figure 6.
These steady-state changes are
the important ones for our attempts
to measure metabolic rates in the
whole cell- especially this last
transition to full reduction when the
PO. is inadequate. It provides the

"'

Fig. 5-The double-beam, difference spectrophotometer. The difference in light
absorption of two beams of different wavelengths are recorded as a function of
time. The resulting graph shows the kinetics of the wavelength-specific absorption changes; for instance, after the addition of a reactant. (Reprinted with permission from M ethods in Enzymology, Chance, 1957.)
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Fig. 6- 0xidation-reduction levels of cytochrome b and NADH1 in suspensions:
of rat liver mitochondria in states 1 to 4. Note the reduction that occurs after
addition of NAD-dependent substrate (tJ-hydroxybutyrate) and the return from
the state - 4 to the state - 3 level upon the last ADP addition. (Reprinted with
permission from Handbook of Physiology, JObsis, 1964, adapted from /. Biol.
Chem. , Chance and Williams, 1955.)
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signal to determine the critical level
of oxygen needed for the cell. In
Table 3 the metabolic states are
listed as they were defined in the
original article of Chance and Williams in 1955. The numbers of the
states correspond to those along the
traces in Figure 6.

in state 3 than in state 4. It depends on the tissue from which the
mitochondria were prepared and
on the type of substrate furnished.
The important conclusion is that
steady-state changes in the respiratory chain components can be
demonstrated in intact tissues when
the rate of o. consumption changes.

filter between the photomultiplier
and the tissue screens out the reflected 366 mp. light. In addition to
being simpler, the method is also
more sensitive than the spectrophotometric one. This is shown in
Figure 1, which shows the response
to a single twitch. Note that the
spectrophotometric cycles of Figure
8 were the responses to 30 twitches.
Since this figure was published,
further improvements have been
made, so that now a response of the
size shown in Figure 8 shows practically no noise. I have actually
performed experiments with a reproducibility within 2% for a
dozen single twitches over a period
of three or four hours.

Studies on Muscle
Showing again my bias as a
physiologist, I do want to emphasize that these changes do not only
occur in mitochondria in a cuvette,
but can also be seen in muscles.
The same double-beam system can
be used. Light of two wavelengths
shines alternately through a muscle
in the resting metabolic state. This
provides the base line for the experiment (Fig. 7). A number of
rapid twitches are induced, ATP is
hydrolyzed to ADP and recovery
metabolism starts. All the optical
changes of Figure 7 are in complete
accord with the notion that we are
observing the switch to rapid metabolism (state 4 to state 3). When
the ATP has been rephosphorylated, metabolism slows down and
the optical density returns to that
of the resting state. NADH and
cytochrome b went through a cycle
of increased oxidation; cytochrome
c went more reduced. The difference between c in the muscle and
the effect listed in Table 3 is not significant. Since 1955 it has been
shown that c can be more reduced

V. Fluorometric Method

Studies on Toad Sartorius Muscle
In addition to spectrophotometry,
fluorometric observation of NADH
is also possible and has great advantages, especially in tissues with
intact blood supply. This method
rests on the fact that reduced NAD
fluoresces when illuminated with
light near its absorption peak at 340
mµ,. It then emits light with a broad
maximum at about 450 mµ,: a
bluish cast comes from the tissue.
Not all of it is derived from
NADH, but a large part is. Since
the oxidized form (NAD+) does
not fluoresce, we now have another
optical measure of the reduction
state of NAD.
This method is actually simpler.
The intensity of the fluorescent light
is measured with a photomultiplier.
The same surface that is exposed to
the excitation light (usually the
366 mµ, line of a high pressure
mercury arc) is used for observation. An appropriate secondary

Studies on Tissue In Vivo
However, we need to know about
the whole tissue, the intact tissue in
vivo. Excised tissue is only one step
in that direction. Now that there is
a method available for looking at
the surface of tissues and saying
something about the reduction of
NAD, we can apply it to tissues
with intact circulation. For observation we can use any exposed tissue,
in our case, most significantly, the
cerebral cortex. The apparatus is
relatively simple. A microscope
with an epi-illumination system
looks down on the cerebral cortex.
Light from an arc lamp is made to
emerge as a cone around the objective of the microscope and is

TABLE 3

Metabolic states of mitochondria and associated oxidation-reduction levels of respiratory enzymes
Characteristics

Steady-State Percentage Reduction of Components
J

State

1
2

3
4
5

[0.l

ADP

level

Substrate
level

Respiration
rate

>o
>o
>o

Low
High
High

High

Slow
Slow
Fast

>o

Low
High

High
High

0

0

Low
~o

Slow

Rate-limitfug
substance

ADP
Substrate
Respiratory
chain
ADP
Oxygen

a

b

c

--- ---

Flavoprotein•

NADH1

7
0

17
0

21

0

0

0

4

6

16

20

53

0

0
~100

1_4
~100

~go

35

40

99

~ 100

l"":"-'100

~100

These values are based on the amount of flavoprotein of the respiratory chain. Other fractions, reduced by anoxia, are
present but disregarded here. [After Chance & Williams]
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focussed on the observed spot.
Emitted fluorescence, as well as reflected excitation light, enters the
objective lens and goes up the. tube.
The latter is filtered out so that only
the fluorescence light remains.
Much of it, but certainly not all, is
that derived from NADH. A photomultiplier measures the light intensity at the level of the ocular.

340-374 mµ Log
DPNH oxidized

~

lo/I :0.()()2

f

30 twitches in 10 seconds
430-410mµ Loglo/'1=0002
cytochrome b oxidized

f

I

Minimal 0 , Requirement of the
Brain

This instrumentation enables us
to evaluate the minimal 02 requirements of the brain. The first type
of experiment to do is the administration to the animal of gas mixtures
low in 0 2. The type of effect we
look for is an increase in fluorescence, signalling that in some parts
of the tissue the respiratory chain
is not furnished with 0 2 and NAD•
goes to NADH. Such an experiment
on the kidney and brain of the rat
is shown in Figure 9. The animal
is switched from air to 100% N 2
or to 3% 02 in N 2 • This results in
a rise in the fluorescence, indicated
by the downward excursion of the
trace in Figure 9. I apologize sincerely for the change in direction.
Dr. Chance and I have always been
opposed in our views about how to
display this, so I am afraid you will
have to switch back and forth
between the experiments that we
did together and the ones that I did
myself. In his case, an increase in
fluorescence is downward, and in
my case an increase in fluorescence is upward.
As expected, an increase in fluorescence accompanies anoxia. Addition of sulfide also increases fluorescence since it blocks the chain at
the level of cytochrome a,.. All other
components of the chain, including
NAD, become reduced. The same
thing can be shown for cyanide and
CO; they all block at the level of a,.
Amytal will also produce increased
fluorescence by blocking the chain,
this time, however, by inhibiting
the flavoproteins oxidizing NADH.
T hese maneuvers with anoxia (or

~

s;JO twitches in 10 seconds

419·405 mµ Log Iojl=0.002
- cytochrome c redUced J,

=

30 twitches in 10 seconds

Fig. 7-Steady-state changes of DPNH (NADH), cytochrome b and cytochrome
c in toad sartorius muscles during oxidative recovery from contractile activity.
The vertical ordinates are one minute apart. (Reprinted with permission from
J. Gen. Physiol., JObsis, 1963.)

determine the level of 0 2 necessary for the tissue? It has been my
experience that most of us tend to
look immediately toward the parameters of circulation, the source
of the 0 2, such as hemoglobin, PO,,
blood flow, A-V differences, etc.
However, although terribly relevant, there is a more basic aspect.
That is the question: What limits
the rate of 0 2 uptake when P02
does not?

hypoxia) and various inhibitors
show that the instrumentation does
perform in the intact tissue as
hoped for.
Limiting Factors in 0 , Uptake

Now we should stop for a
moment and reflect on the exact
question of the day. We are asking: What are the parameters that

i

FLUORESCENCEl
--+---+---DECREASE

2%

I
i _

TOAD SARTORIUS

~

11.7 °C

T.C. 5.5 aec.

Fig. 8-Fluorescence cycle induced by an isometric twitch. Toad sartorius muscle. A decrease in NADH concentration would be registered in a downward
direction. (Reprinted with permission from J. Gen. Physiol., JObsis and Duffield,
1967.)
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Studies on Cells

First we should discuss what happens in intact cells. We can measure the rate of oxygen uptake as
a function of the partial pressure of
oxygen in the cuvette. Diffusion
problems from the blood vessels to
the cells are sidestepped. In Figure
10 we see such an experiment for
yeast cells. The same thing has been
done wi th other cells. It is im-

portant to obtain a good measurement of the P02 at which the rate
of oxygen uptake is decreased. It is
immediately obvious from the two
sets of experiments that the presence of glucose makes an enormous
difference on both the rate of oxygen uptake and the P02 at which the
plateau rate starts to fall. The important point is that in the absence
of glucose, the availability of substrate was the limiting factor long

Rot Brain
Rot Kidney

100% - + - 30/o

100•1.----f

~2min~
!-- Manual Ventilotion--oj

\--- 2min---<\

A

B

Fig. 9- Fluorescence changes induced by anoxia or severe hypoxia and by sulfide (an electron flow inhibitor) in the kidney and brain of rats. The top line
shows the periods during which different gases were respired. An increase in
NADH concentration would be registered in a downward direction. (Reprinted
with permission from Science, Chance et al., 1962.)
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Fig. 10-The rate of oxygen consumption of yeast cells in succinate buffer as a
function of P02. Top curve: glucose added as substrate. (Reprinted with permission from Handbook of Physiology, JObsis, 1964, adapted from J. Cellular
Com. Physiol., Winzler, 1941.)
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before the P02. Succinate, although
metabolized rapidly, penetrates
slowly and thus provides only inadequate substrate levels in the
cells. Those experiments were,
therefore, run in a semi-starved
condition. The PO, at which the
two systems begin to show signs
of being limited by o. availability
are 2.5 and 0.21 mm Hg. This tenfold difference is the result of the
difference in rate of metabolism
due to substrate limitations. When
you ask me what the limiting level
of 0 2 is, I will have to ask you,
first, what the rate of respiration is
in terms of total capacity and, then,
what is limiting the rate? Because it
could also quite well be that the
limit is not the substrate but the
blocks accompanying a decreased
demand for oxidative phosphorylation .. The effects of these two causes
of a less than maximal rate will be
slightly different, but, for the moment, that is of secondary importance.
One can make a rather complete
mathematical description of the respiratory chain system, if that is
necessary and useful. Then one can
calculate a number of constants,
such as the apparent Km for 0, ;
extrapolate the data to infinite concentrations of 0 ., substrate, ADP
and inorganic phosphate; and
finally come out with a limiting
value for P0 2 near the mitochondria. I have done my homework on
this and the calculated, "corrected"
curves are shown as broken lines
in Figure 11. In this way I obtained
values of approximately 0.5 mm
Hg (l,uM0 2) for 50 % inhibition
and 5 mm H g (9,uMO.) for a 10%
loss in 0 2 uptake. However, the
numbers have little meaning except
as upper limits. Any time the rate
of 0 2 uptake is not maximal, these
minimal levels will be considerably
lower; in the case of nearly starved
yeast, perhaps 25 times.
The figures above are for conditions in which the respiratory chain
is the only limiting factor. However, as I said, that is hardly ever
the case. Usually the system is
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limited either by the rate of oxidative phosphorylation or by the
substrate supply. This is difficult to
distinguish. It turns out that the resting metabolism of most cells-at
least the ones that we have looked
at-is not limited by a lack of ADP
only. During resting respiration
they do not have fully reduced
levels of mitochondrial NAD such
as isolated mitochondria have.
There is also a subtle but very
effective control of the substrate
level. In resting metabolism the
substrates are not present in excess.
So there must be at least one other
control step, but most likely there
are several. We do not really know
where they are located except that
they are not in the respiratory
chain. This type of control operates
only in the intact cell, not in isolated mitochondria. In all tissues
that we have studied there is this
very definite limit of substrate provision. This limitation is overcome
immediately upon initiation of
more active oxygen uptake. In
other words, there is a multipronged control system of overall
oxidative metabolism. Physiological
activity produces an increase in
oxygen uptake and oxidative phosphorylation by an increase in ADP,
but at the same time it spurs substrate provision. It certainly can do
so by increased glycolysis. This results in an increased availability of
pyruvate for the citric acid cycle.
Apparently there are similar controls in the other pathways feeding
into the Krebs cycle. Of course,
there is an absolute necessity for
meeting the increased needs. Happily, in an experiment it is often
possible to get around this problem
by increasing the substrates from
the outside.
Dr. Patterson: Could you define for
some of us the K m02?
Dr. Jobsis: My apologies. The
shorthand stands for the Michaelis
constant for oxygen.
Let me define it very pragmatically. If one does a plot of the rate
of oxygen uptake as a function of
the P02, one comes up, as I showed

with a curve which looks something
like those in Figure 10. It is useful
to talk about that level of oxygen
where the rate is 50 % of the maximal rate. It is often referred to as
the apparent Km. When I was quoting numbers for the K mo2, I was
talking about the more theoretical
system, i.e., when one would
have provided all conditions so that
only the respiratory chain was limiting. The higher the rate of 0 2 uptake in the experiment, the closer
one is approaching the true K mthe real point of reference for the

respiratory chain as an enzyme system.
Question: Is this the Michaelis formulation applied to your system?
Dr. Jobsis: Yes, but, of course, it
is only a pragmatic constant. A
midpoint or 50 % point is
usually better defined than a "perceptible decrease." Therefore, I
often like to use the experimental,
the apparent Km0 2 •
Question: Wouldn't it be a P02,
then, corresponding to that 5 µ.M?
Dr. Jobsis: No. The K m number is
0.5 mm Hg or lµ.MO ,. One can
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Fig. 11- The rate of oxygen consumption as a function of 0 2 concentration for
ascites tumor cells (curve 1, 37°C), liver cells (curve 2, 40°C), and isolated
liver mitochondria (curve 3, 20°C). The maximal rate observed experimentally
(solid lines) is given the value 100. The upper curves (dashed lines) were calculated after extrapolation of the experimental data in the hypoxic range to infinite
0 2 concentration by a Lineweaver-Burk plot. The lines on the right-hand margin
indicate the theoretically achievable maximal rate unlimited by the supply of
reducing equivalents. (Reprinted with permission from Handbook of Physiology,
JObsis, 1964.)
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use about 10 times that level as a
lower limit for p lentiful 0 2, i.e., 5
mm Hg or about 9µ,M. That is an
average for 10 % decrease in O,
uptake rate, as shown in Figure 11.
I'm not very interested in that number, however, because it's a nonphysiological one. It is calculated
for the system when the respiratory
chain is the only limiting situation,
and that is hardly ever the case, if
ever.
Question: Micromoles per what?
Dr. Jobsis: Micromolar-i.e. , micromoles per liter of fluid .
Studies on Animals
In the physiological case the
number of interest is, of course, the
one for that undefined condition
when substrate is partially limiting.
We would have to make some
really awful generalizations to define it. In addition we would have
to tackle the job of calculating the
PO, midway between capillaries
from blood flow and blood content
data. There are too many badly
known parameters to inspire real
confidence. Instead we can use the
experimental approach that is made
possible by our ability to determine
the adequacy of the P02 by observing the respiratory chain directly.
We will find that PO, in the inspired air at which we first see
NAD going reduced.
What Chance and his co-workers
did was to combine a double-beam
reflection spectrophotometer with
a fluorometer, both of them looking
at the same spot on the cerebral
cortex (Chance, Schoener and
Schindler, 1964). The spectrophotometer shows the changes in the
color of the hemoglobin as it goes
from the oxygenated to the disoxygenated form, and the fluorometer gives a measure of the adequacy of the oxygen for the
respiratory chain . What is really being measured in this tissue is the
behavior of the source, which is
hemoglobin, in relation to that of
the sink, which is the respiratory
chain. In addition, we would like to
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have something physically located
in between-myoglobin might be
just right-but the brain does not
contain that, of course.
In the experiment an animal is
respired on different gas mixtures.
This is the independent variable
and is given on the ordinate of
Figure 12. It is, of course, a much
different scale of PO;, than in the
previous figure . Starting out at 150
mm Hg, we find a situation where
we have certain values of the currents of the photomultipliers associated with the normal tissue. The
difference between these and the
currents recorded when the animal
is completely anoxic, we give the
value of 100 for both the spectrophotometer and the fluorometer.
These values are set out on the ordinate. Now we let the animal respire on a mixture low in 0 ,, and
we will look at the hemoglobin to
see how much of it is in the oxygenated form and at the NADH to
see if it goes up, i.e., shows signs of
hypoxia. For each gas mixture you
get two points: an average tissue
PO, from the hemoglobin and an index of the adequacy of 0 , provision
to the mitochondria from the flu-

0

orescence. At about 40 mm Hg inspired, the method did not see
anything but disoxygenated hemoglobin. Actually that means less
than about 10 % oxygenated Hb,
because that is the level of confidence of these measurements. At
the same time the fluorometer recorded that the level of fluorescence had gone up only 35 % . In
other words, most of the cells were
not yet anoxic. A further decrease
in the inspired PO, finally resulted
in complete anoxia as defined by a
stable, high intensity of fluorescence.
Before we decide upon a limiting
PO, value, we should discuss one
other property of the chain . It concerns the interpretation of the increased NADH level in terms of
effects of O, lack, and it arises from
some kinetic considerations. The
real O, sink is, of course, reduced
cytochrome aa, because that is the
one that reacts with oxygen. It
turns out, again from mitochondrial
experiments in cuvettes, that when
one follows the rate of oxygen uptake as a function of the PO, one
will notice many members of the
chain at a more reduced level be-
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Fig. 12-Blood oxygenation level and NADH fluorescence in the intact cerebral
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as a percentage of the total change produced by complete anoxia. (Reprinted
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fore a measurable change in the
rate of oxygen uptake occurs. The
reason is a perfectly straightforward one, arising from chemical
kinetics. Since reduced aa reacts
with oxygen, the reaction rate is
proportional to the reduced aa concentration times the O, concentration. Under conditions of plentiful
0 2 , cytochrome a, is only 1 % reduced or less. There is, therefore,
an enormous capacity for cushioning the effect of low P02 on the
reaction rate. All that is needed is
an increased level of reduced aa.
This is what occurs automatically
when o. starts getting scarce, since
it will take longer before a reduced
a, molecule and an o. molecule will
collide. Over the range of hypoxia
the reduction of a3 is reflected further and further down the chain by
increased levels of reduction of the
other components. The last one to
be affected significantly will be
NAD. Roughly speaking one can
use a value of a measurably increased NADH level (10 % ) as an
end point. Here the cell reaches the
detrimental range of hypoxia.
Question: This is an intracellular
oxygen tension?
Dr. Jobsis: No. In Figure 12 we are
speaking of the P02 in the gas
mixtures. The numbers on the ordinate are oxygen tensions in the
respired air. Practically speaking
this is, of course, the crucial number. From another point of view,
however, we might want to know
the average P00 in the tissue at
which 10 % reduction of NAD
occurs in brain mitochondria. This
turns out to be, again, about 5
mm Hg; in this respect the brain
mitochondria are not greatly different from other mitochondria.
However, this number is of limited
value only. The tissue level of O.
varies, of course, depending on the
distance from capillaries. This is the
best we can say at the moment.
It is also possible to approximate from the oxygen dissociation
curve of rat hemoglobin the average capillary PO,. When N AD reduction due to hypoxia is about

10% complete, the spectrophotometric signal shows that hemoglobin is still 20 % in the oxygenated form. Assuming for the brain
tissue an average venous P02 midway between arterial and venous
blood (i.e., 70 mm during the airbreathing part of the experiment),
then 1/ 5 the difference in signal
between that level and the anoxic
one gives us, from the 0 2 saturation curve for rat hemoglobin, a
PO. of 25 mm Hg. This is again a
gross average, this time between
venous and arterial fractions. Perhaps the only usab le numbers will
come out of fluorometric experiments such as those shown in Figure 12, with or without the differential spectrophotometer trace.

Re fe rences
CHANCE, B. Techniques for the assay
of the respiratory enzymes. In
M ethods in Enzymology. S. P. Colowick and N. 0. Kaplan (eds.).
Vol. 4. New York: Academic Press,
1957, pp. 273- 329.
CHANCE, B., P. COHEN, F. ]OBSIS, AND
B. SCHOENER. Intracellular oxidation-reduction states in vivo. Science 137: 499- 508, 1962.

CHANCE, B. , B. SCHOENER, AND F.
SCHINDLER. The intracellular oxidation-reduction state. In Oxygen in
the Animal Organism . New York :
Pergamon, 1964, pp. 367-388.
CHANCE, B. AND G. R. WILLIAMS.
Respiratory enzymes in oxidative
phosphorylation. I- III. J. Biol.
Chem. 217: 383- 427, 1955.

Limitations of Fluorometric Method
I believe that these, then, are the
results and the present state of the
art. There are a number of limitations to the method as it stands at
the moment. The main one is a
limitation in resolving power. We
are limited by the penetration of the
excitation light into the tissue. So,
at the moment there is not much
sense in decreasing the lateral dimensions, i.e., decreasing the diameter of the optical field. The
problem is that fluorescence from
a depth of a millimeter still contributes to the signal. That is, of
course, terribly much. One possibility is the use of a different line
of the mercury arc, say, the 330
mµ. line. In that region there is a
sizeable change in the depth of
penetration of light with shorter
wavelengths, but while 330 mµ.
penetrates Jess deeply, it is also
more harmful. In other words,
there are problems, but perhaps
they can be overcome step by step.
This is where I want to stop.
Discussion of this paper will be
after the coffee break, and I would
like to start the discussion by
covering two slightly different
points.

JOBSIS, F. F. Spectrophotometric studies on intact muscle. I, II. J. Gen.
Physiol. 46 : 905-969, 1963.

JOBSIS, F. F. Basic processes in cellular respiration. In Handbook of
Physiology. Sect. 3. R espiration.
Vol. 1. W. 0. Fenn and H. Rahn
(eds.). Washington, D.C.: American
Physiological Society, 1964, pp. 63124.

JOBSIS, F. F. AND J. C. DUFFIELD.
Oxidative and glycolytic recovery
metabolism in muscle. J. Gen.
Physfol. 50: 1009- 1047, 1967.

KEILIN, D. On cytochrome, a respiratory pigment, common to animal,
yeast, and higher plants. Proc. Roy.
Soc. (London), Ser. B. 98: 312-339,
1925.

KREBS, H. A. AND H. L. KORNBERG.
A survey of the energy transformations in living matter. Ergeb. Physiol. Biol. Chem . Exptl. Pharmakol.
49: 212-298, 1957.

v. P. The R elationship of
Oxidation and Phosphorylation in
the Respiratory Chain. Moscow:

SKULACHEV,

Academy of Sciences of the
U.S.S.R., 1962.
WINZLER, R. J. The respiration of
bakers' yeast at low oxygen tension.
J. Cellular Comp. Physiol. 17: 263-

276, 1941.
181

OXYGEN TENSION
DISCUSSION

Dr. Patterson: Our discussion session now will concern this marvelous and beautifully delivered material that Dr. JObsis has given us.
I do want to introduce a gentleman
who has come at the suggestion of
Dr. Doolan, our associate dean, to
help us discuss some material that
is so basic and so difficult for a
number of us: Dr. Lutz Kiesow,
who is head of the division of molecular energetics at the Naval Medical Research Institute. I think Dr.
fobsis would like to show two slides
before the quizzing begins.
Dr. Jobsis: Thank yo u for indulging
me once more. I would like to
bring up two more things, and since
they are a little distant from the
previous focus, I thought it would
be best to wait until after the coffee
break.
I have looked at the fluorescence
of the cerebral cortex from a functional point of view, trying to relate
physiological activity with levels of
fluorescence. The activity I have
studied is paroxysmal firing induced
by strychnine or Metrazol. The experimental system was the cat with
an exposed cerebral cortex, electrodes on the pia mater and microscopic observation of fluorescence.
With this arrangement it is possible
to show that a decrease in fluorescence accompanies each burst of
epileptiform activity. A considerable amount of instrumental development has shown that this is not
an artefact caused by increased
blood vessel diameter. Monitoring
of that, as well as the administration of 10 % C02, which maximizes
vessel diameter even in rest, has
shown the reliability of this observation.
These results show that it is possible to distinguish between less active and more active physiological
conditions by the relative intensity
of the fluorescence, i.e., the relative
intensity of the metabolism. Jn
terms of the scheme of Chance
and Williams (Table 3), the extra
physiological activity tends to force
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the respiratory chain further away
from the resting level (state 4) to
the active level (state 3). The fact
that it is possible to show this in
the intact tissue is the first point I
wanted to make.
The second point concerns, perhaps, a minor issue that can be settled with the fluorescence method .
For quite a while it has been known
that epileptiform discharges are accompanied by increased metabolism
and an expansion of the cerebral
vascular bed . Because of this knowledge it has been speculated that the
end of a paroxysmal burst of high
voltage EEG activity might well be
brought about by the occurrence of
anoxia in the cortex. This I am now
able to deny. Under normal respiratory conditions, oxidations are invariably noted without a trace of a
tendency toward the increased fluorescence that is characteristic of
anoxia or hypoxia. It is possible to
produce signs of hypoxia during an
attack, but either very low gas mixtures must be administered during
the experiment or a very low rate
of artificial respiration must be
maintained. In addition, under such
conditions signs of hypoxia may
occur during an epileptiform burst
without much effect on the further
progress of the burst. Apparently
the discharges can continue for
some time without the need of continuous oxidative restoration of the
,.._, P energy stores required for recouping the loss of ions.
Dr. Worsham: Are we to understand that the length of these episodes would be the same as without
anoxia? Have you terminated the
episode by the anoxia?
Dr. Jobsis: Your understanding is
correct; the burst is not terminated
by anoxia .
Dr. Patterson: Is yo ur burst the
equivalent of a convulsive seizure?
Dr. Jobsis: Right. Usually they are
produced by strychnine and Metrazol together. It is a horrible mixture, but it's very effective.
Dr. Patterson: The floor is open for
quizzing. I think we'd like to hear

from the members of our panel
first.
Dr. Kiesow: I think what has to be
done here is to correct a few things .
First of all, there is your extremely
modest presentation of your contribution to a rather important field
of modern cell physiology. You
mentioned Britton Chance and his
almost 20-year-old efforts of analyzing and characterizing the cellular
respiratory chain and its elements.
But I think your contributions are
almost as, important as his, since
you made the step back to the physiological system. You freed yourself
from this dangling sword of Damocles of being a mitochondriac, and
you went back to as intact and as
physiological a system as you
could find . In this context I would
like to ask a question or two. One
has to realize, of course, that the
mitochondriac working with either
mitochondria, or even subunits
thereof, quite often has the advantage of less interferences caused by
cell constituents such as substrates,
coenzymes and enzymes. These are
present in intact cells but are frequently absent in mitochondria and
their subunits. The question, therefore, concerns your studies on the
fluorescence of either tissue in situ
or of muscle when excited with
light of a wavelength of 340 or 366
m,u. To what extent does this fluorescence really reflect changes of the
NADH concentration alone, and
to what extent does it reflect changes
of total of intracellular pyridine
nucleotides--NADPH as well as
NADH? I would also be interested
in data which would break down
the intracellular pyridine nucleotides of your biological materials
into the NAD and the NADP system. Furthermore, as you subdivide
the total, what are the ratios of the
reduced over the oxidized forms of
both systems?
Dr. Jobsis: This is such an invitation to expand! Dr. Kiesow has put
his finger right on a very sore spot.
I've thought a lot about it and done
some experiments. I can gladly give
some answers, although I'm sure
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they will not be as complete as he
would like to have them. This is a
very important point, and I did not
go into it only because one has to
limit a lecture in some way.
Next to NAD (nicotinamide adenine dinucleotide) there is NADP
(nicotinamide adenine dinucleotide
phosphate), which is the same
molecule with an extra phosphate
on the ribose of the adenosine. This
is also contained within the mitochondria, and when it is reduced, it
has very much the same absorption
and fluorescence properties as
NADH. It is also involved in certain mitochondrial reactions. This
is not the only possible source
of confusion, since, in addition to
mitochondrial NAD and NADP,
there is NAD, which is not in the
mitochondria but in the cytoplasm.
It is involved in glycolytic metabolism, which is, of course, highly active. I am sure this will be brought
up later on. Finally, there is another fraction of NAD in the mitochrondria which is, as far as we
know at the moment, not too directly in equilibrium with the chain.
It is not reduced directly by substrates but by a so-called reversed
flow of electrons. For this reducing
equivalents flow in the opposite direction, as usual; that means uphill
in an energy diagram. This costs
energy, of course, and high-energy
phosphates or high-energy intermediates are needed to do this. I
don't want to go too far into it. It
does not add to the present discussion. I just wanted to bring it up
to show that the picture is complex.
Let us go from the easier part
of the question to the more difficult.
The NAD in the cytoplasm is glycolytically active. This fraction does
not interchange freely with that
which is in the mitochondria. In
fact, NADH added to isolated mitochondria will not be oxidized. There
is a separate pathway for intercommunication of reducing equivalents,
but it doesn't concern us here because the problem is: Since it is
NADH and becomes alternately
oxidized and reduced, how do you

know that you're not partially measuring it? The only indications I
have are some studies on muscle,
excised muscle, where we looked
very hard for possible cytoplasmic
effects in the presence and absence
of iodoacetate. There was no contribution that we could see. This
appears puzzling, because the concentrations are very similar. Happily
for us, the fact is that NADH has
a tremendously increased fluores.cence efficiency when in mitochondria. It fluoresces. up to 20 times
more intensely per concentration
unit than it does in solution or,
apparently, in the cytoplasm. This
is the reason why our signal is derived, as far as I can see, from
mitochondrial NADH.
NADPH is a different problem.
It is involved in various other biochemical steps, and it is also oxidizab le and reducible and should
contribute absolutely the same type
of signal. There are two points that
save the day. First, there happens
to be very little NADP present
compared to NAD. Second, both
Dr. Chance and I, independentlyDr. Chance for liver and I for brain
-have analyzed biochemically for
NADP. In my case, the experiments were closely related to the
fluorescence experiments. We measured the fluorescence in one spot.
We produced a maximal decrease
in fluorescence with strychnine administered i. v. and took a sample
from the other hemisphere. In other
words, in the middle of a strychnine
attack we froze a piece of tissue
and removed it. Next we let the
brain go fully anoxic by apnea and
took a second sample right in and
around the point of optical observation. Then we analyzed with enzymatic methods and compared
left side against right side, anoxic
against oxidized. It turns out that
the NADPH concentration doesn't
change in such an experiment,
while the NADH does and, incidentally, shows a good correlation
with the increase in fluorescence.
So, we're pretty sure that NADPH
does not interfere. Dr. Chance has

been able to pick up some signs of
an effect in the liver but with slow
kinetics. In other words, he has
seen NADPH changes, but they
were at a different rate than the
fluorescence and the NADH
changes.
In conclusion, then , we appear
to be rather safe. However, there
remains the cytoplasmic fraction of
NADH. We cannot analyze for it
differentially. It is probably also
affected by some of the same
factors that affect electron transport.
The only reassurance is the fact
that, in various other preparations
such as muscle, it has been shown
that its quantum efficiency of fluorescence is some 10 to 20 times less
than that of NADH associated with
the oxidative phosphorylation function of the respiratory chain .. That
is the answer, I think.
Dr. Kiesow: You were referring to
the problem of energy-linked reversal of the electron transport. If
I remember correctly, Chance recently published a paper where he
demonstrates that this step is affected by hyperbaric oxygen. He
claims that this effect is not due to
an increased rate of autoxidation
of reduced flavoprotein , but is due
to a direct effect of hyperbaric
oxygen on this reversal of the electron transfer. What would you consider to be hyperbaric conditions
here; hyperbaric in regard to oxygen, that is?
Dr. Jobsis: If you want a hard
number, I'm sure I cannot give it
to you. I think anything that produces a level higher than about
30 to 40 mm Hg-averaged tissue
P0 2 is probably hyperbaric. That's
the range for which you need a
hyperbaric chamber. But I'm not
too well acquainted with hyperbaric
work. The experiment that you
refer to was the following. When
mitochondria are exposed to high
oxygen pressure (5 to 12 atmospheres) it appears that one inhibits,
the reduction of the N AD fraction
which receives its reducing equivalents by reversed electron flow (the
pathway that goes from succinate
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via fiavoproteins to NAD). Exposure to hyperbaric oxygen prevents NAD reduction upon the
addition of succinate. This is suggestively linked to some measurements of Sanders, Woodhall and
their group in which they have
shown that very high levels of succinate in the blood protect against
cerebral damage by hyperbaric oxygen. (A. P. Sanders, I. H. Hall,
P. J. Cavanaugh and B. Woodhall.
In Proceedings 3rd International
Conference on Hyperbaric Medicine. I. W. Brown, Jr. and B . G .
Cox (eds.). Nat. Acad. Sci.-Nat.
Res. Council, Publ. No. 1404, pp.
73-82, 1966). The suggestive implication is that a tremendous
amount of succinate-and these are
really enormous levels they are
working with-produces a protective effect by partially overcoming
this inhibition. However, I don't
believe that Chance has been able
to verify this by direct observation.
Until now, regardless of the dose
of administered succinate, he just
hasn't seen it.
Dr. Robin: Dr. JObsis, I would like
to join my colleagues in thanking
you for this superb discussion, and
I won't end that compliment by
using a harpoon. I should like to
ask you a question. It's a self-serving one, because after you answer
it, I would like to make a comment,
regardless of how you answer the
question. I think that one of the
purposes of a conference like this
is to highlight matters that are of
potentially great interest for the
future in the areas that are being
discussed. The question that I
would like to ask is : Are there data
available concerning whether the
peroxidase pathways, the non-cytochrome pathways involving energy
generation, are linked, on one hand,
with ATP generation and, on the
other hand, with acetyl Co-A as
an intermediary? In other words,
how closely are they linked to the
usual kind of oxidative phosphorylation?
Dr. Ji:ibsis: Well, I'm very glad that
you gave me a choice of any
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answer, because I am not too well
acquainted with these systems. I
have looked into this matter a bit,
since I worried that these reactions
might affect the mitochondrial reaction. Being a rather pragmatic experimentalist, I immediately stopped
going into further details when I
found that they did not seem to
hinder my system of measurement.
Hence, I would really like to hear
your comments.
Dr. Robin: What I should like to
indicate is that the area of noncytochrome-linked energy generation is, in my opinion, a potentially
very important one and that there
are at least two physiological circumstances that I know of in which
the possibility of non-cytochromelinked energy generation has been
raised. With your permission, Dr.
JObsis, I might indicate these.
One system is the alveolar macrophage, which is being extensively
investigated by a number of
workers, including my colleague,
Dr. Bernard Gee. This fits in with
this type of audience, because there
are lung types and heart types, and
one of the important functions of
the alveolar macrophage, of course,
is to phagocytize inert, dead bacteria,
and living bacteria. Almost certainly
this is an endergonic, an energy-requiring process, and one can establish this by several lines of evidence,
but one of the most striking lines
of evidence is that, if you measure
the oxygen consumption of the
alveolar macrophage in its resting
state and then let it gobble up dead
bacteria, there is a brisk increase
in oxygen consumption .. Now, if
you manipulate this system by partially inhibiting cytochrome b by
using antimycin, or you use cyanide
and partially inhibit aa so that the
cells are still living, there is obviously a profound decrease in oxygen consumption, but there is no
effect on phagocytosis. There is evidence which indicates that, although
the general level of oxygen consumption is decreased in these cells,
there is still, at this reduced oxygen
consumption, an increase under

circumstances of phagocytosis. Obviously, the easiest way to reconcile these data would be to say that
there must be another energy link,
another oxygen-requiring process,
which does not involve the respiratory chain.
The second system is the nucleated red cell of the shark, and
the findings to be discussed are
probably characteristic of most nucleated red cells. Unlike mammalian
red cells, nucleated red cells are
brisk oxygen consumers. One can
measure oxygen consumption in
these cells by standard methods.
One of the important energy-requiring processes in red cells generally is the process by which
sodium is transported from the inside of the red cell to the plasma
against an electrochemical gradient. If one is interested in energetics, one is, of course, anxious to
quantitate the metabolic costs of
performing this transport work.
(Dr. Ji:ibsis's colleague, Dr. Tosteson has spent a good part of his
professional life in this area.) Now,
if you take this cell and inhibit anaerobic glycolysis by using one of
the standard inhibitors, there will
be a marked decrease in sodium
transport. So, presumably, the
major energy source for this transport process is anaerobic glycolysis.
If you take large doses of cyanide
and you inhibit the respiratory
chain, you get no change in transport. This raises an important
question, because presumably both
respiratory chain activity and anaerobic glycolysis result in ATP generation. How can the cell distinguish between the ATP which is
being generated oxidatively, which
is not available for transport, and
the ATP that is being generated by
anaerobic glycolysis? Even more interesting than this is the finding
that exposure of cells to nitrogen
leads to a decrease in transport
rate. I can summarize these results
as follows. Let us assume the normal sodium transport rate is 15
mEq Na+/kg red cell H.O per hour,
transported from the inside of the
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red cell to the outside. If one stops
anaerobic glycolysis, the transport
rate falls to 5 mEq Na•/kg red cell
H.O. If one cuts out the respiratory
transport chain by either antimycin
or cyanide, the transport rate remains at 15 mEq Na•/kg red cell
H.O. On the other hand, if one decreases oxygen availablity by exposing the cells to 100 % nitrogen,
the transport rate falls to, say, 8
mEq Na•/kg red cell H.O. This
suggests that some aliquot of energy
cost for this process is being mediated by non-cytochrome oxygen
consumption, and the sum total of
this is, then , as I said at the beginning, that non-cytochrome-mediated energy generation is probably
a much more important field than
has been appreciated in the past
and may be a "hot" area of work
in the future . Would you comment
on this?
Dr. Jobsis: I am very glad to hear
these data. For the last half year
a graduate student, Mr. Hersey, and
I have been looking for these kinds
of systems. I guess we will just have
to go to the Caribbean and catch a
shark or two.
I would like to point out one
thing. Earlier in my presentation I
talked about autoxidative flavoproteins, and I mentioned that there
is no known energy-saving step.
High energy phosphate is definitely
not being formed. This could really
say something else again, namely
that energy utilization, although not
mediated by ATP, might perhaps
be a direct function of the membrane components without the intervention of ATP. It is a most
important point. Altogether, I'm
very glad indeed that this gives us
a good excuse to go to the Caribbean around Christmas.
Dr. Carter: I have just three short
questions: 1) Does the fluorescence
generation result in any significant
temperature change of the tissue?
2) Have you thought of the possibility of using a fiber optic to come
beneath to limit your depth? We've
had some success in using fiber optics in kidney, in other words, pok-

ing in and coming up. It sounds a
little drastic, but remember that
these penetrations are very small,
and it's conceivable that you would
have a known depth of un-damaged
kidney and brain under these circumstances. And finally, 3) Could
fluorescence possibly be used as a
measurement of blood flow? I
should certainly like to hear a little
more about why fluorescence is
related to blood flow. Specifically,
we would be very much interested
in measuring blood flow on the
surface of the kidney.
Dr. Patterson: If I remember correctly, you actually said you corrected the fluorescence for changes
in blood flow, and I was fascinated
by the possibility that this technique might be used to measure
blood flow.
Dr. Jobsis: I didn't measure it; I
just got rid of it.
Your first point, Dr. Carter, was
about the temperature. We have a
highly filtered light beam. Practically all infrared is eliminated. In
addition, we have measured the
temperature by using a small thermistor, enclosing it in a drop of saline
and putting that on top of the cortex. The rate of heating is insignificant as long as the blood supply is
intact. This carries heat away very
effectively. However, if you stop
the circulation, in a dead cat, for
example, you have a slight rise in
temperature; but there is greater
danger in direct radiation damage
of the tissue. We don't know the
mechanism, but it is signified by
pinprick hematomas appearing in
the optical field. This is much worse
for the shorter wavelengths. The
366 mµ, line is a good compromise
between effectiveness of NADH excitation and relative lack of damage.
The second point was about the
fiber optics. First of all, I didn't
know one could go down to that
small dimension. I'd love to talk
instrumentation with you for a
while after the meeting. This certainly sounds very exciting. There
is a problem which I'm sure will
be solved in the near future, and

that is that the last time I looked
into fiber optics, the index of refraction of available materials was such
that the wavelengths of light between 300 and 400 mµ, were not
transmitted well by the fiber optics.
I'm sure that something can be
done about it. I'm not sure that I'm
the right person to try to do it,
though.
Comment from audience: There
are plastic ones now available.
Dr. Jobsis: They are very bad at the
moment, because plastics have some
absorption in that region. For small
thicknesses it is no problem. In fact,
all my cuvettes and muscle chambers are made of lucite, but they
are limited to about a millimeter
of thickness in the light path. If
you're going through fiber optics,
however, you are working with centimeters.
Comment from Audience: But
you've got too much light, anyway,
you said.
Dr. Jobsis: Well, that's relative. An
additional problem is a faint blue
fluorescence excited by 366 m µ,.
Now, the final point about blood
flow. This was very much a headache, especially changes of blood
content in the field. Hemoglobin
will diminish the fluorescence in
two ways. First, it will absorb excitation light, and then it will absorb the emitted fluorescent light.
When light penetrates a red cell ,
practically all the 366 mµ, light is
absorbed, and almost the same
occurs for the fluorescence. Therefore, the problem that you face is
the following. You are looking
down on an optical field on the
surface of the tissue. Through the
field run capillaries, venules, and
arterioles. By eye, it looks very
much like a network of black
threads running through a blue
background. Lateral and depth
resolution are not sufficient to avoid
anything but the very largest vessels. When something increases the
metabolic activity, blood flow increases either by an opening up of
more capillaries or by distention of
vessels. The effective field from
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which you are recording decreases,
therefore, every time you have an
increased distention of the vessels.
Excitation light is scattered in
the tissue, and some of it is picked
up by the objective. This fraction is
affected by changes in blood volume
in much the same way as the
fluorescence . With appropriate optical beam-splitters and filters, it
can be measured and provides a
control for the light absorption
changes affecting the fluorescence.
I have often wondered whether
these changes in the scattered 366
mµ, light might not provide the
basis for a useful means of monitoring blood flow parameters.
Dr. Patterson: You are actually not
correcting the change of blood
flow, but the changes in blood
volume.

Dr. Jobsis: Correct.
Dr. Worsham: It is really farther
removed than that. What you are
really correcting is the amount of
hemoglobin in the field.
Dr. Jobsis: Yes. You see more
hemoglobin in the field due to distention of the vessels. Incidentally,
the response time is quite good.
The time resolution is in the neighborhood of two seconds.
Dr. Patterson: We would now like
to throw this program open to
general questioning of our distinguished speakers.
Dr. Huf: I have two questions.
The first one is related to the problem which the first discussant raised
about the importance of specific
factors located outside of the mitochondria. I am now raising the
question of the importance of unspecific factors. Take the muscle,
for instance. When you throw the
muscle into activity, you are bound
to get all kinds of unspecific
changes, membrane changes, protein contraction, pH changes, osmotic changes. Hence, you don't
really look at a specific system, let's
say the B system, in the same physicochemical environment. To what
extent do unspecific factors, the
kind mentioned, affect at least the
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transient changes and, perhaps,
steady-state changes as well?
The second question deals with
the point which you made about
the significance of the rate at which
metabolites enter into cells. 'Vhen
you come into the region of very
low oxygen tension, would it be
useful to consider as a limiting
factor the rate of oxygen supply?
You do have a high oxygen diffusion coefficient, but you have reduced the oxygen gradient to practically nothing; so it comes, as it
were, to a competition between
limiting factors. You may have a
high concentration of substrate of
low mobility, or you may have
a low concentration of oxygen
which bas a high diffusion coefficient. So, what is limiting?
Dr. Jobsis: Let us start with the
second question first. We are pretty
sure that oxygen is limiting at very
low P02 levels; say, less than 0.5
mm Hg. Above that there is a large
region in which we can not decide
what the limiting factor is. With
tissues, and especially tissue slices,
it probably would be the low P02
due to diffusion path lengths. There
is no telling when this is the case
unless you do an experiment with
varying P02 levels. The uncertainty
about the diffusion is, of course,
part of all considerations of this
nature. Fortunately, most cell membranes do not exclude either 0 2 or
C02, so no significant new barriers
are erected.
There is one aspect of the control of a sequence of reactions that
escapes the uninitiated. I think Dr.
Worsham has some very significant
things to say about this. The problem is that most of our kinetic
thinking is derived from enzymes
in a cuvette or a test-tube. We can
throw a substrate in and measure
how fast it is converted. %en you
have added an insufficient amount
of substrate and you see a decrease in the rate, you know immediately and quite correctly that
your substrate concentration has
limited the velocity. However, in a
mitochondrial system and even

much more so in cells, there is a
very complex situation with many
control points. Take, for instance,
the glycolytic chain. There is
usually plenty of glycogen, yet
lactate formation does not proceed maximally. Here there may be
as many as six different control
points. In the mitochondrial system
itself there are three already in
oxidative phosphorylation. There is
not one primary control point; each
one of the sites of oxidative phosphorylation provides control, and
the rate becomes different if you
take just one away. There is, therefore, a very complex interaction,
complex enough to boggle the mind
really. One needs to use computers
to represent all the individual rates
and their influences on each other.
However, at very low oxygen levels,
I think it is. warranted to say oxygen is limiting and, of course, in a
tissue, oxygen diffusion is one of
the limiting factors.
As to your first point, yes, there
is a tremendous amount of difficulty
with non-specific changes. Just
fro m an instrumental point of view,
it is difficult, because when a muscle contracts, it scatters light quite
differently than when it is in the
resting condition. The double-beam
method is necessary to overcome
this. For a first approximation this
is all right. However, light of different wavelengths is not scattered
equally. Low wavelengths are scattered more intensely than high
wavelengths. %en your expected
absorption is very small , this will
get in the way. Then you must use
two reference wavelengths, straddling the wavelength that you want
to measure. In other words, if I
want to measure 550 m 1.t, I use as
reference 540 and 560 mµ,, thereby
getting rid of most of the wavelength specific effect. However, the
increase in scatter is not linear with
the wavelength; it is a power function, and one has to correct also
for that.
Dr. Worsham: It depends on the
direction of scattering, too, unless
you have a spherical molecule.
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Dr. JObsis: That doesn't bother us
too much, because that effect is
not too wavelength specific. It's a
very correct point, but pragmatically we don't worry about it much.
Now, your final point. There are
not only instrumental difficulties,
but physiochemically a contracted
muscle is a different system. We can
o nly rely at this point on changes
we can observe in mitochondria in
cuvettes and compare them to those
in the tissue. It turns out that we
don't get too many differences by
changing any extracellular parameters. The functions we are studying are rather insensititive to pH.
Only large pH changes show anything, and I have some data on
changes in intracellular pH relevant
to this.
Dr. Huf: What are large changes of
pH?
Dr. JObsis: .2 of pH unit, or something close to that.
Dr. Huf: How much does the pH
change when the muscle contracts?
Dr. JObsis: I have looked at the
pH changes after small amounts of
contractile activity and before glycolysis is stimulated. During glycolysis really large changes occur in
the internal pH. But keeping away
from lactic acid formation as best
you can, pH changes occur as a
result of a single twitch, which are
in the neighborhood of .05 pH
unit. Other people have looked at
this long ago and found the same.
Then there may be osmotic
changes. They are very unpleasant
when they are large. It looks, however, as if that does not occur in
the muscle cell, with the possible
exception of some increased osmotic pressure due to long term
a noxia. In general, we have covered
the difficulties pragmatically, but we
certainly have not stopped trying
to study each for its own worth.
Question from the Audience: At
what level of hypoxia does this
reaction of strychnine disappear
completely?
Dr. Jobsis: You mean an increased
EEG? I have not tried that. The
spontaneous EEG disappears some-

where in the neighborhood of
breathing 3 % to 5 % oxygen, at
least in our blissfully anesthetized
animals. I really don't know at what
level of PO;, the paroxysmal, strychnine-induced EEG stops.
Dr. Kontos: I was wondering whether your method is fast enough to
observe any rapid spontaneous
changes in living muscle, for instance, in response to changes in
blood flow. The records you have
shown before you interfered with
some particular intervention looked
pretty close to straight lines. Is this
true?
Dr. JObsis: These muscle records
were from excised muscle, so we
avoided that problem. Dr. Stainsby,
Dr. Renkin and I have planned to
investigate that a bit later this fall.
Dr. Renkin is specifically interested
because of possible changes in capillary distribution, distribution of
open and closed capillaries. Dr.
Stainsby is interested in the relation between lactate production
during exercise and possible hypoxia in muscles doing different
kinds of work. I am just interested.
Dr. Worsham: I want to make a
comment, if I may, but first I want
to ask a question. I'd like to ask
how well we know the characteristics of each step along this cytochrome chain. Do we know the
rate constants and the Michaelis
enzyme constants all the way along
for each step?
Dr. Jobsis: We do not know
enough, but we know approximately. You can observe each component of the respiratory chain with
the exception of cytochrome c,.
Many of the rate constants are
well determined, although one always wishes for better.
Dr. Worsham: I'd like to suggest
that perhaps the time has come for
you to join forces with the theorists,
if you classify yourself as a pragmatist, and go ahead and try to
simulate your system from the
known in vi tro characteristics of
these various steps. The best thing
you could hope for is that your
computer simulation, a model built

up from the known isolated characteristics, would then agree with
what you see in some of your experiments. I am impressed with how
well you have cut out a lot of
complications. This is always the
place to begin for a good theoretical approach; in fact, you think like
a theorist and work like an experimentalist, but you have done the
best experimental job of getting a
real simple system to study. Perhaps you have a chance now of
building a model, putting it on to a
fairly modest computer and trying
to see if your model does agree with
what you have observed. One needs
theory to program an analog computer to simulate the reactions that
occur in a metabolic pathway. D r.
JObsis has well indicated the nature
of the problem. He wiggles the
oxygen concentration at one end of
the chain, and he wants to know
what happens to the NADH rate
turnover at the other end of the
chain. This problem is not easy to
solve.
Dr. Patterson: Well, you are teaching kinetics of reversible processes,
and a lot of these are irreversible.
Dr. Worsham: That's not true. The
difference is that the metabolic systems in the animals we have studied
have no beginning. That's really the
difference. There's no C. in the
processes that you study. There's a
steady state you can think of, a
metabolic steady state; you perturb
this, and it goes to another steady
state. What I'm saying is that the
kinetics you think of as pot kinetics
are quite different from the kinetics
of steady-state metabolic path rates
to add itional steady states.
Dr. Kiesow: I completely agree that
the problem here is the flow kinetics
-rather the pot kinetics-and I
was just wondering, since it obviously is a question of measuring
the intracellular oxygen concentration with an indicator as close as
possible to oxygen, whether you
have ever tossed around the thought
of using the photodissociation of
the carbon monoxide complex of a3
as an indicator for intracellular
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oxygen? The second question: Although the autoxidation contributes
to only 10% of the total oxygen
consumption, it should have, and
it does have, the characteristic of
being much more proportional to
the partial pressure of oxygen than
this a,, which is very low saturation
pressure. Isn't it possible, perhaps,
also to use the state of the redox
system at the level of flavoprotein
as an indicator for intracellular
oxygen pressure based on the autoxidation where the rest of the
chain is hooked off by either an
inhibitor, antimycin A, or cyanide
or carbon monoxide?
Dr. Jobsis: Actually I'd like to go
in reverse order, which is not too
pleasant, but I don't think that
would be an insurmountable problem. From the specific to the more
general, I have never thought of
using the autoxidative fiavoproteins as indicators. However, it
sounds like a very, very good suggestion indeed if we can be sure we
have blocked the other fiavoproteins. We need cyanide. That can
be solved. A bit of difficulty lies in
trying to get an index to fiavoproteins. They have rather weakly differentiated spectra. However, a colleague of all of us in this field, D r.
Jose Ramirez of Mexico City, who
unfortunately died in a car accident, had, at the time of his death,
completed a system of fluorescence
measurements of fiavoprotein that
he thought was very promising. I
am sorry to say that progress on
this ceased with his death ..
As for the remark of Dr. Worsham, I really wanted him to come
up with this very important point
that we are not working in the
same type of chemical kinetics as
that so often found in textbooks.
Dr. Worsham: You mean they
taught you the wrong thing?
Dr. Jobsis: Yes, for this purpose it
is wrong. Recently, however, the
physical chemists have been getting more interested in such systems. I am glad that they are correcting themselves. I should be
more humble at this point, because
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I am a rank amateur in computer
work, but I love to play around
with computers and sometimes have
to tear myself away from the analog
because it's so wonderfully neat.
You put in the values, the curves
come out beautifully, and you
think, "Now I'm doing science!"
Of course, you're not doing science
at all, because a dirty experiment is
really what science is made of. To
interpret a dirty experiment, however, you need an analog computer.
Although I've done a bit of this
sort of work, this is being done very
intensively at the Johnson Foundation by a whole group of computer
people. In fact, they have made a
system, starting out with glucose
and some other substrates in glycolysis, taking in the whole respiratory chain and taking ATP consumer reactions into account, also.
Dr. Worsham: Have you tried their
model to simulate your experiments?
Dr. Jobsis: No. I, myself, have not
played with the analog computer in
this system. I have played with it
in the interpretation of energy turnover in muscle contraction.
Dr. Worsham: Why don't you go
to their computer and say, "Let
me ...
Dr. Jobsis: Well, they are doing
this, so I am just waiting for them
to do it. Of course, sometimes they
don't ask the right questions.
Dr. Worsham: That's where they
need you.
D r. Jobsis: Yes, but you'll have to
convince them of that. There are
two fe llows, each with his own
group; one working with an analog
computer group, the other with a
digital computer group. By the way,
I think they have purposely been
put next to each other to produce
some healthy competition.
D r. Worsham: By the way, your
comment was excellent. Thomas
Huxley said, "The great tragedy of
modern science is the slaying of a
beautiful theory by an ugly fact."
Dr. Robin: Two comments. Dr.
JObsis, maybe this afternoon I can
provide you with an animal in

which you can completely knock
out a, and have both the animal
and the brain survive for at least
one to two weeks. Secondly, since
we're being philosophical and comparing the differences between how
things work in a complicated cell
and a complicated animal, macromolecules and ions being put in
a test-tube with some water and
shaken up together, I think the
problem is even deeper than that.
We have no c.. In many kinetic
processes the kinetic changes that
take place depend on the previous
point along the curve, and, therefore, if we are describing any of
these multicomplicated steps, we
have to describe them each in terms
of a family, at best. Consequently,
I am not sure you've been teaching
the wrong kind of physical chemistry. I am not sure that the right
kind of physical chemistry yet
exists which can accurately define
these kinds of systems, and, therefore, what we try to do is try to
make the best approximation we
can with the method and thinking
that is available until, hopefully,
somebody comes along with a
physical-chemical-theoretical structure which can deal with variables
which change so rapidly.
Dr. Patterson: Haven't people like
Dr. Prigogine, working with thermodynamics of irreversible processes, and others studying the irreversible processes helped somewhat
in this area?
Dr. Robin: Yes, although I think
you are referring to something that
is a little bit different. The difference between reversible and irreversible thermodynamics is involved in your question. The basic
assumption that is made in classical thermodynamics is that you deal
with equilibria, and, of course, in
living systems there are no equilibria. The consequences of not having equilibria are that the best you
can deal with are steady states or
quasi-steady states, and the general equations that apply to each of
these two different approaches are
quite different.
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I have been asked to discuss
methods of measuring intracellular Pco, and to discuss the physiology and biochemistry of intracellular C02 tensions. Actually, I am
in a relatively fortunate position in
that my difficulties in discussing the
methodology of intracellular Pco,
measurements are considerably less
than those which face my two colleagues. The reason for this becomes apparent if one analyzes the
following quantitative relationships.
Gas Exchange
Let us consider a simple model
of a cell and its blood supply. I
have arbitrarily divided this blood
supply into an inspiratory portion
at the arterial end of the capillary
and a mixed expiratory portion at
the venous end of the capillary. To
simplify analysis of the relationship
between blood gas tensions and intracellular gas tensions, I have made
certain assumptions with respect to
this model.
1. It is assumed that the fluid
which circulates through the vascular channel is plasma and plasma
alone. It is assumed that there are
no red cells or hemoglobin contained in this plasma. Although one
can derive an expression for cellular gas exchange in the presence of
hemoglobin (capable of combining
with 0 2 and CO, ), it is a more complicated equation, and, therefore,
analysis is based on hemoglobin-
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free plasma. This is not an unreasonable assumption, for there
are living systems which receive all
of their O, supply from plasma .
For example, tunicates apparently
derive required O, solely from
plasma despite the fact that this
species has "green" blood cells containing a vanadium pigment which
does not function as an 0 2 carrier.
An Arctic fish studied by Ruud
lacks hemoglobin. Other animals,
like some teleost fish, have rather
low hematocrits, averaging between
6% and 9%. The assumption that
O, carriage by hemoglobin is absent is, therefore, not an unreasonable one.
2. It is assumed that gas exchange between cell and plasma
occurs entirely by passive diffusion.
No special mechanisms for either
O, or CO, transport are involved.
3. It is assumed that the rate of
blood flow through the capillary is
slow enough to allow establishment
of complete gas tension equilibrium
between cell and plasma at the venous end of the cell.
A relations_hip between mean 0 ,
and CO, tensions in the cell can
now be obtained as follows. The
amount of CO, given off by the cell
as the plasma flows from the arterial to the venous end of the
capillary is equal to the rate of
plasma flow times the solubility coefficient of CO,, a, (which, as you
know, relates content of C0 2 to
tension of CO, ) times the difference
in partial pressures at the expiratory and the inspiratory ends of
the vessel. Expiratory and inspiratory Pco... may be regarded as
equal to the plasma Pco, at the
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arterial and venous ends of the
vessel, respectively, in accordance
with the third assumption stated
above. In a similar fashion we can
quantitate the oxygen uptake for
the cell as being equal to the flow
times the solubility coefficient for
oxygen times the difference in Po2
in the plasma at the arterial and
venous ends of the capillary. Dividing one equation by the other gives
the respiratory exchange ratio (RQ).
The flows cancel out, and one is
left with the ratio of solubility coefficients for CO. and 0 2 times the
respiratory quotient (R). This equation may now be solved for the
mean plasma Po, at the expiratory
side of the cell. The result is:

P E:o, = Pro , -

a C02
-R1 x a02

· (P Ec o, -

Prco,)

(1)

Inserting reasonable values for these
parameters, one can then solve for
the variable that we are interested
in, namely PEco,· The mean PEo,
is unknown. Its absolute value is not
important, however, for the calculation of the C02 tension inside of
the cell. We shall assume a high
value, say, 40 mm Hg. By definition, P10 , is equal to the P 0 , of
arterial plasma, namely, 90 mm Hg.
R has a value very near to "one."
The solubility for C02 and 0 2 ratio
depends upon temperature and
upon ionic strength, but under the
present conditions (mammalian
temperature and ionic strength)
this ratio equals about 20/ 1. The
partial pressure of C02 in the inspired fluid, Pico,, is equal to the
arterial C02 tension, which is 40
mm Hg. One may now examine
the effects of changes of these independent variables on the value
of PEco, • the dependent variable.
One can show that, lowering PEo,
from 40 mm Hg to 1 mm Hg, the
P:Eco, ( = intracellular P co, by definition) increases from about 42.5
mm Hg to approximately 45 mm
Hg. Thus, for very large changes of
PE0 ,, the effect on PEco, is very
small. A change of RQ, from its
maximal value of "one" in the
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steady state to a minimal value of
around .7, changes the value of
intracellular Pco, by only 0.5 mm
Hg. The ratio of gas solubilities is
relatively constant. Therefore, despite a wide spectrum of changes
in the relationship of all of the
other factors, there is a very close
relationship between the Pco, of
venous blood and PEco" i.e., the
Pco, inside the cell. In other
words, C02 is so soluble and its
diffusibility so high in comparison
with oxygen that measurements of
Pco, in venous blood must closely
approach the mean Pco, inside the
cell. If one can obtain an approximate value for the Pco, in a given
organ, that is to say, if one can
measure the Pco, of the venous
blood which drains that organ, one
can approximate the value of intracellular P 00 , . This approximation is
likewise acceptable for calculation
of whole body intracellular Pco, if
the calculations are based on measurements of mixed venous blood
Pc 0 , . Since venous plasma is a
homogeneou:s fluid in which measurements can be made with reasonable accuracy, one can closely
approximate a value for mean
intracellular Pco,·
I would like to contrast this situation with that faced by both of
my colleagues in this seminar. Dr.
JObsis has implied that, from the
standpoint of cellular metabolic
processes, "mean" oxygen tension
probably signifies little, because
one needs to know the values of the
0 2 tension at those sites in the cell
where the various 0 2-consuming
reactions are taking place. Precise
analysis of the quantitative aspects
of oxidative metabolism within the
cell are very difficult.
There are two possible mechanisms by which O, enters from capillary blood into the cell. One
possibility is that 0 2 diffuses into
the cell as a result of partial pressure difference between arterial
capillary plasma and intracellular
fluid. Those portions of the cell
with the most extensive O, consumption receive the most O, be-

cause they are consuming it more
rapidly, thereby producing a greater
partial pressure difference, which
in turn insures an adequate supply
to the involved sites. If this is true,
then there must be parts of the cell,
for example, the cytoplasm, which
have a partial pressure of O, close
to that of arterial plasma, and other
areas, such as the mitochondrion,
that may have a partial pressure of
O, of approximately 1 mm Hg. Although the concept of "mean o.
tension" may be useful for some
purposes, it has little validity in
describing the nature of O, exchange at those intracellular sites
where 0 , exchange occurs.
The second possibility to explain
oxygen entry is that simple diffusion
does not explain the transport of
O, into the cell. Even under these
circumstances, say, the existence
of a special O, carrier, the bulk
of evidence indicates that there is
a spectrum of 0 , tensions within
the cell.
The situation is as difficult when
one deals with H• concentrations
inside the cell. One may agree with
Dr. Carter that H+ inside the cell
is in thermodynamic equilibrium
with H + in extracellular fluid; or
one may agree with others who
take the viewpoint that thermodynamic equilibrium for H • exists
in some cells, like the red cell, but
that in other cells the mechanism
for H + distribution is obscure. At
any rate, it seems quite clear that
the H + concentration inside the cell
is different from that of plasma.
The main problem in understanding
H + relationships within the cell is
the problem of H• concentrations
at particular sites where H ' is involved in modifying protein structure or reaction rates. It is interesting to note that an important
issue in contemporary biochemistry
involves the question of whether
intramitochondrial pH is 2.0 or 6.0.
At present such questions cannot be
answered definitively.
It appears, then, that, in considering intracellular gas tensions, one
is on more solid ground with the
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very diffusible gas C02, because the
differences between it inside cell
water and venous blood cannot be
large.
The Pco2 in venous plasma d,epends upon, among other things,
the amount of C02 produced and
the amount of blood ventilating the
cell. One of the important factors
which determines the value of
venous plasma Pco2 is the level of
inspired Pco2 , which is, of course,
the arterial Pco2 level. The latter,
in turn, is determined by the total
CO. output of the animal or human
subject and the alveolar ventilation.
One must now raise the questions:
What is it that sets the level at
Pco2 = 40 mm Hg in man living
under normal circumstances? and
Why is it that in certain animals the
Pco. may be as low as 1 mm Hg?
A survey of Pco. data obtained on
a variety of animals is given in
Table 1. For a bony fish, a shark
and a tadpole, the Pco2 values are
1.8 mm, 4.0 mm and 1.5 mm Hg,
respectively. When the tadpole has
developed into a frog, Pco2 becomes approximately 20 mm Hg.
The African lung fish, which, despite its name, is an air breather,
has a Pco2 of approximately 19
mm Hg. Turtles and seals have
Pco;s of 23 mm Hg and 42 mm
Hg respectively, as compared to
humans with a Pco2 of 38 mm
Hg. An analysis of such data reveals an apparent bimodal distribution of Pco2 which operates in
such a way that animals that exTABLE 1
Pco. Tensions In Vertebrates
I. Aquatic Gas
Exchangers
mmHg
Teleost
1.8
Elasmobranch
4.0
Tadpole
1.5
II. Aerial Gas Exchangers
Lungfish
19.0
Turtle
23.0
Man
38.0
Seal
42.0
Frog
19.0

change gas in an aquatic environment have very low C02 tensions
in their body fluids, generally
below 5 mm Hg. Animals that exchange gas with atmospheric air
generally have CO. tensions above
10 mm Hg, sometimes as high as
40 or 50 mm Hg.
To explain this bimodal distribution of CO;,, one m~y use the gas
exchange equation ( 1). Instead of
applying the equation to a single
cell, however, let us apply it to the
whole organism, and let us assume
for simplicity that Pico, is equal to
zero. Equation 1 may then be written as follows:
P'Eco ,

= (Pro, - PE'oJ

a 02 X R (2)
a C02

Assuming reasonable values applicable to: a) aquatic gas exchangers, and b) aerial gas exchangers
(man), one finds:
a) PEc o, = (150-100) X 1 X
1/ 35 = 1.4 mm Hg (18°C)
b) PEco, = (150-110) X 1 = 40
mm Hg (37°C)
For aerial gas exchangers the gas
solubility ratio does not, of course,
enter into the calculations.
It follows from this that the very
low Pco2 tensions found in aquatic
gas exchangers is dictated by an
obligatory requirement for o. and
the ratio of the solubility of CO, to
the solubility of 0 2 in water.
Electrolyte, pH Relationships

Let us now consider the relationship between Pco2, HCOa-, and
pH. This is expressed by the wellknown
Henderson-Hasselbach
equation:
P

H

= p

K'

+ log [HCOa]
p

a Ico,
There is only a relatively narrow
range of pH which is compatible
with life. Therefore, for a fixed pH,
[HCoa-J must be high or low if
Pco2 is high or low. The highest
[HCOa-] found in aquatic animals
with a low Pco2 is approximately
9 to 10 mEq/ 1, as compared to
man and other mammals with a

relatively high Pee,. Here [HCOa-]
is, on the average, 25 mEq/1 and
can be as high as 35 mEq/1 (Table
2). Thus, the bimodal distribution
of Pee, referred to earlier is accompanied by a bimodal distribution of [HCOa-J.
Once the level of [HCOa-l is
determined, it becomes clear that
the level of the other major extracellular anion, c1-, must be determined. Since electroneutrality
must be maintained, aerial gas exchanging animals with a high
[HCOa-l must have a low [Ci-] in
contrast to aquatic gas exchanging
animals in which one finds a low
[HCOa-l and a high [CI-]. It therefore seems that the anion pattern
of plasma in lower animals as well
as in man is dependent on an
obligatory requirement for 0 2 and
the form of gas exchange necessary
to provide the o..
Let us now look at what the consequences of those relationships are
on renal function . The kidneys are
chiefly responsible for establishing
and maintaining in plasma the
proper [HCOa-l and [CI-], which
are dictated by the law of electroneutrality. The renal tubule operates so that there is, more or less,
an inverse relationship between the
amount of rcr-1and the amount of
[HCO,-] which is reabsorbed from
the glomerular filtrate. Therefore, it
appears that the renal pattern of
conservation of the main anions
depends, in the last analysis, on the
TABLE 2
Bicarbonate Concentrations in
Body Fluids of Vertebrates
I. Aquatic Gas

Exchangers
mEq/ l
Teleost
4.0
Elasmobranch
7.0
Tadpole
6.0
II. Aerial Gas Exchangers
Frog
12.0
Lungfish
12.0
Turtle
32.0
Man
25 .0
Seal
27.0
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mode of gas exchange and on an
obligatory requirement for o•.
One is tempted now to present
certain biochemical features of the
evolution of animals, as follows.
The most primitive form of energy
production is anaerobic glycolysis.
Under these circumstances significant amounts of CO. are not produced, and the C02-[HCOa-l pair is
not an important buffer system. As
animals developed 0 ,-consuming
pathways, they required O, for
energy production to maintain life.
A definite relationship between
Pco2 and PO, had to be established. Under some circumstances
this led to a high Pco,, while
other circumstances resulted in a
low Pco2 of body fluids. This, in
turn, determined the electrolyte
pattern of extracellular fluid and,
presumably, intracellular fluid. It
also determined specific patterns of
renal function. It, thus, appears that
the metabolic pathways that were
so beautifully outlined by Dr. Ji:ibsis
have an interesting general biological meaning. Many functions of
animals which, a priori, seem to
be isolated phenomena, depend on
the simple fact that a given amount
of 0, is required for energy metabolism, and the pattern of these
functions evolves as a consequence
of the operation of the physical
chemistry of gas exchange between
animals and their environment.
Let us now consider CO, as an
acid. A fruitful way to examine the
effects of CO, on acid-base equilibria in animals is to analyze socalled whole-body, C02 titration
curves. One exposes the animal to a
range of Pco.'s and then determines the effect of these Pco,'s on
the pH and [HCOa-l of arterial
plasma. The range of Pco. changes
in tensions in man and animals
living at an ambient 02 tension of
150 mm Hg is extensive. Pco, can
vary from several millimeters of
mercury in the shark to at least 100
mm Hg in man and dog.
Let us consider the quantitative
aspects of pH changes in dog, man
and shark. First of all, if one com192

pares acute pH changes in dog obtained from the data of Schwartz,
when Pco, is changed from 40 mm
Hg to 140 mm Hg, with pH
changes occurring "chronically,"
when dogs are placed into a CO,rich atmosphere for three weeks,
one finds a smaller change of pH
with changes in Pco,. In other
words, within a given Pco, range,
the acute increases of plasma in
[HCOa-l are much smaller than
changes that take place when the
dog is chronically exposed to CO,.
It may be that the acute increase
in [HCOa-l during the first 12- to
16-hour period takes place largely
as a result of buffering of carbonic
acid, especially by OH- groups in
intracellular fluid . Increase in
[HCOa-l in animals exposed chronically to elevated Pco2 not only
reflects buffering but also reflects
H+ excretion by the kidneys. Exposure to high Pco,, either acutely
or chronically, however, will lead
to lower pH values in plasma. In
other words, extracellular pH is
not fully protected by an adequate
generation of bicarbonate.
There are two possible general
explanations of this finding. One
explanation is that the ability of the
animal to generate sufficient
[HCOa-l to normalize extracellular
pH is limited by either buffer capacity or renal function, or by
both. This appears unlikely, since
the [HCOa-l generated at high
Pco2 values would be adequate to
normalize pH at intermediate Pco,
values. The animal is clearly capable of generating a higher [HCOa-l
than he does at intermediate Pco,
values. Therefore, a functional
limitation involving buffering or
renal H + excretion does not appear
likely.
The other possiblity is that the
regulatory mechanisms involved are
not geared to maintenance of a
normal extracellular pH. This possibility requires emphasis since hypercapnic human subjects, unlike
dogs, may maintain extracellular
pH within normal limits until a
relatively high Pco, is reached. To

explain this fact, various theories
have been presented. It has been
suggested that such data are unreliable. This is unlikely, because
similar findings have been reported
by several independent investigators. The existence of a normal extracellular pH in the face of chronic
hypercapnia is not unusual in man.
The second theory that has been
advanced to explain the data is that
a normal or even high pH suggests
the presence of superimposed disease. If a patient has a high Pco.
and a normal pH, he may have
developed independent metabolic
alkalosis. The difficulty with this
theory is that, frequently, one is
unable to find clear-cut evidence of
superimposed metabolic alkalosis.
A third theory (our own) suggests
that patients with chronic hypercapnia may regulate intracellular
and not extracellular pH. Furthermore, it is suggested that intracellular regulation may be associated with low, normal or even
high extracellular pH values.
Data were obtained by a young
colleague of mine, Dr. Tushan, who
studied a group of patients with
moderate hypercapnia using the
DMO technique to calculate wholebody intracellular pH and intracellular pH of muscle on biopsy
samples. It was shown that the
mean values for whole body intracellular pH and muscle pH are not
significantly different from each
other or from normal values,
regardless of the level of extracellular pH. I should emphasize
that this is not incontrovertible
proof, but it is at least consistent
with the theory that the regulatory
mechanisms called upon when conditions of high Pco. exist are
located in areas in the body which
are not readily definable but are
presumably intracellular in location.
I would now like to call your attention to the data from the shark,
because the findings are dramatic
and because I think they illustrate
a rather important point. When the
shark's Pco2 is elevated from 4
mm Hg to 12 mm Hg, his extracel-
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lular pH remains unchanged. The
reason for this is that the animal
generates bicarbonate extensively.
For example, at Pco2 = 12 mm
Hg, the [HCo.-1 is approximately
15 mEq/ l. A two- to three-fold increase in Pco2 results in an increase
in [HCo.-1, with maintenance of a
normal extracellular pH. It is remarkable that this maintenance of
extracellular pH is accomplished by
intracellular buffering.. No increase
in H • secretion in urine or increased
H • excretion by the gills is detectable. We are unable at present
to explain this admirable performance of the shark. (It is possible
that this remarkable degree of
regulation occurs as a result of the
characteristics of body buffering of
H.co. in the low Pco2 range and
could also be observed in man if
man could live under such conditions.) It is also possible that the
shark has some special mechanisms,
not found in man, for buffering the
augmented H .co. resulting from an
increase in inspired CO•. Obviously
more work is needed to find out
which mechanism, or mechanisms,
are involved.
I would now like to mention
briefly the metabolic consequences
of exposure to high and low Pco2 •
There are a number of reactions in
man and other vertebrates in which
CO. plays a role. To my knowledge
there are in man no biochemical
reactions in which C02 concentration is rate limiting. It should be emphasized, however, that an increase
in Pco. leads to alterations of certain functions. For example, respiratory alkalosis damages brain
function. Very high Pco2 can induce seizures followed by narcosis.

Anaerobic Energy Metabolism
Stimulated by the lecture of Dr.
JObsis on oxidative, energy-liberating pathways, I would like to
conclude my presentation with a
discussion of anaerobic energy production, which has not been discussed in this seminar.
There are at least four reasons

why animals die when they undergo
severe 0 2 depletion. Dr. JObsis has
already given one reason, namely,
that, with loss of 0 2-dependent reactions, energy production fails or
ceases. Secondly, there is the loss,
at least in mammals and in most
vertebrates, of central nervous system integrity. There may be something about oxygen, aside from its
ability to provide energy, that is
necessary in vertebrate systems for
the structural and functional integrity of the nervous system. Thirdly,
animals suffering from oxygen depletion lose biosynthetic ability. In
many biosynthetic reactions, oxygen
acts as an obligatory oxidant for the
synthesis of many important compounds. Fourthly, animals can die
because of acidosis, which occurs
as follows. As the oxygen supply
becomes limited, the animal
switches to anaerobic glycolysis, the
end product of which is pyruvic
acid. Pyruvate accumulates, as does
lactate, its reduction product, along
with other organic acids of the
Krebs cycle. Thus, there is an accumulation of organic acids, which
are proton donors, and the animal
develops severe acidosis. This, combined with severe hypoxia, may become a limiting factor in survival.
Several years ago I inaugurated
studies on pond turtles (Pseudemys). This species is able to dive
for periods of several days. It was
formerly believed that during diving
the turtle respired by pulling water
through the cloaca into two accessory bladders. I investigated this
possibility by placing a plaster cast
in the turtle's cloaca and blocking
gas exchange through the buccal
mucosa by taping the mouth. It
turned out that there was no respiratory exchange under these circumstances, and the turtle survived
under water for one to two weeks
despite a total absence of external
oxygen supply. Within a few hours
the oxygen tensions in lung, in arterial and venous blood dropped to
zero. The animal survived with 0 2
tensions at essentially zero. The
turtle was also able to survive in

pure nitrogen. It likewise survived
in the absence of cytochrome-dependent metabolism, as was demonstrated by blocking cytochrome Ca
with cyanide or by blocking cytochrome b with antimycin. Blood
lactate levels rose from 1 mEq/ 1 to
40 to 60 mEq/1 over a period of
seven to ten days, indicating that
the major energy source was anaerobic glycolysis.
The precise mechanisms of anaerobic glycolysis under these circumstances is not known, but they
may very well involve the pyruvate-lactate system. Pyruvate occupies a key position between anaerobic glycolysis and the aerobic
pathway. Pyruvate can be interconvertibly reduced to lactate through
the action of a group of isoenzymes
which are collectively known as
LDH (lactic dehydrogenase). In
most vertebrates there are two basic
kinds of LDH. There is an MLDH
(muscle LDH) and an HLDH
(heart LDH), the synthesis of each
being under separate genetic control. The five isoenzymes which are
found in most vertebrates represent
the five possible permutations of
these two polypeptides occurring
as tetramers. Thus, there is an M,,
an M.H,, an MJI,,, an MiH., and
an H,.
MLDH is biochemically quite
different from HLDH in a number
of respects. According to Kaplan
and his co-workers, MLDH, but
not HDLH, is insensitive to inhibition with pyruvate ion. This means
that if MLDH is dominant over
HLDH, pyruvate is converted into
lactate, possibly by supplying NAD,
thus augmenting anaerobic glycolysis. On the other hand, if HLDH
is dominant over MLDH, lactate
will be converted into pyruvate,
which is fed into the Krebs cycle
and used in the oxidative metabolism. Thus, dominance of MLDH
favors anaerobic glycolysis; dominance of HLDH stimulates oxidative metabolism. Although the role
of the two forms of LDH in anaerobic glycolysis, as outlined here, is
not fully established, there is good
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evidence that the amount of MLDH
or HLDH that is available, at least
under some circumstances, is dependent on ambient 0 2 tensions.
Hypoxia is associated with high
MLDH; aerobiosis with high
HLDH levels. We have found that
whole turtle homogenates and homogenates prepared from heart,
brain, liver, or turtle serum have
only one LDH, and preliminary
work shows that this LDH is of
the M type. This may be looked
upon as a fortunate evolutionary
development, because it is the presence of MLDH which, in part,
makes it possible for the turtle to
survive by anaerobic glycolysis
without 0 2 living. The question may
now be raised: How does the turtle
survive severe acidosis for days or
weeks? The turtle has an anatomical
compartment which is known as the
coelomic cavity. It is equivalent to
the peritoneal cavity in man, and
the turtle may be likened to a patient suffering from liver cirrhosis
in that the coelomic compartment
has in it a volume of fluid which
represents about 6% or 7 % of
total body weight. This fluid contains 100 to 120 mEq/1 of bicarbonate, as compared to plasma,
which contains approximately 32
mEq/ 1. This compartment is also
fairly permeable to lactate ion. The
coelomic fluid , then, represents a
relatively large reservoir or buffering bicarbonate solution, which
provides for adequate protection
against acidosis during diving. Indeed, one finds that, after diving,
the bicarbonate concentration of
the coelomic fluid decreases, while
the lactate concentration increases.
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Dr. Patterson: Dr. Robin is open
for quizzing.
Dr. Jobsis: As the lactate is freed
by the body, it reacts with the very
high concentration of bicarbonate
here. Before that time there must
have been an equilibrium. In other
words, doe s the pH ch a nge
vary greatly, or is C0 2 excreted by
the animal?
Dr. Robin: No, you see be is diving. He cannot excrete CO., so the
system is not as efficient as if he
had open egress to air to get rid of
the excess CO,. On the other hand,
in real life I imagine that pond
turtles do not very often dive for
as long as one to two weeks, and,
therefore, the ability to come up
for air a nd to get rid of CO. is
present in life.
Dr. Jobsis: What is the normal pH
of the coelomic fluid?
Dr. Robin: Control values are~ 8.2.
The fluid is like a solution of threetenths molar Na• bicarbonate. During prolonged diving, the pH falls;
lactate rises; bicarbonate decreases;
and the Pco2 rises sharply so that
the animal has two sources of
Pco2 , the most important of which
is due to the buffering of hydrogen
ions by bicarbonate.
Dr. Regelson: It cannot only be
that, though, because Sanford Siegal, exobiology researcher of Union
Carbide, using the red-eared turtle
for survival studies, found that, at
atmospheric pressures of 20,000
feet with near zero oxygen (0.1 % ),
there is 24-hour turtle survival in
this system. He claims that there is
no circulation in the turtle under
these circumstances, yet it stays
alive; the blood sludges, and there
is no movement of blood in the
blood vessels. There is also a species
of ocean perch, the Arctic perch,
which has no hemoglobin but gets
along.
Dr. Robin: But that does not apply
to the diving turtle.
Dr. Regelson: No, not to the diving turtle, but the turtle can still

live 24 hours with no circulation at
all before it dies.
Dr. Robin: Well, what I really tried
to imply by describing the coelomic
compartment and anaerobic glycolysis is that, in animals which adapt
to living under conditions of oxygen
depletion, one seldom finds a single
mechanism to explain survival.
Generally there are a number of
adaptations. There is another adaptation in the turtle. When the animal dives, he decreases blood flow
to his pulmonary circulation, and
the blood flow then goes to what
would be the equivalent of the left
ventricle in man. He thereby supplies more substrate to his tissues.
Apparently, to get around the problem of inefficient energy generation,
one needs a number of different
tricks.
Dr. Carter: I am not sure I have
any quizzing. With reference to bicarbonate concentrate in the kidney,
as Dr. Robin mentioned, in the
final analysis the kidney must set the
concentration. This has some meaning in the curves that you showed
regarding acute and chronic. That
is, it has been shown, for example,
that the bicarbonate Tm, or the
maximum amount of bicarbonate
that is reabsorbed, will go up in a
dog exposed chronically to increased CO, atmospheres. In other
words, that is an adaptive mechanism. We assume, and I do not
think anyone has any measurements
to prove it, that the same thing
occurs in man. The reason we do
not have measurements that are
very good is that experimentally it
is very difficult to put man in a
C0 2 environment. T he only people
that have been really successful at
this are the submariners in situations where CO. concentration in
submarines has been up around
6% . In case you have not tried it,
just picking up a mask full of CO,
is a hilarious experience, to put it
mildly and that is not the least of
your worries. As soon as you stop,
you will feel like you are about to
die. So, this is a tough human
experiment.
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Jn considering the shark, perhaps
the most pertinent animal is the rat;
because the rat is not like the dog.
The bicarbonate Tm in the rat normally is close to 18 mM higher than
the serum bicarbonate normally
maintained. That is a peculiar circumstance, but it seems to be quite
true. In other words, in the case of
man and dog, the bicarbonate Tm
is at any given moment pretty well
equivalent to what the serum bicarbonate is. This is not true in the rat,
where the Tm approaches the equivalent of 38 to 40 mM bicarbonate
in the plasma. For this reason, when
you give a rat CO. rebreathing, he
immediately has a very rapid increase in serum bicarbonate and
tends to have a somewhat blunter
range of pH change, although it
ultimately does become acidotic.
The whole thing is over in 24 hours,
whereas it may take as long as several days in the dog. I wonder
whether the same thing is not true
in the shark-that the Tm for b icarbonate must be at all times
higher than what the bicarbonate is
in the plasma. Otherwise the shark
would not retain the bicarbonate
when one raised the Pco2, unless
one wanted to make an inordinate
curve for the action of Pco2 in the
bicarbonate Tm. Do you have any
measurement of that?
Dr. Robin: The shark kidney is insensitive to any measured parameter to changes in either C02 tension, bicarbonate or hydrogen ion.
That is to say, if one takes the
animal and loads him with bicarbonate, this changes neither the
urinary pH or urinary bicarbonate
concentration nor urinary amonium
excretion or urinary titratable acidity. The presumption is that, since
his pH under these circumstances
returns to normal, excretion takes
place through the gill and, for reasons which are not entirely clear,
the shark kidney essentially does
not respond to changes in extracellular pH by "appropriate" activity.
There is no possibility of defining
Tm under these circumstances.
Dr. Carter: Did I understand you

to say that the gill excretes bicarbonate?
Dr. Robin: Yes.
Dr. Carter: Does it do this continuously or only when bicarbonate
concentration is raised? And if it
does it only when the concentration is raised, at what point does
one have to raise it to see bicarbonate in the gill effluent? In other
words, the Tm in the gill conceivably is in excess of the serum concentration, which would amount to
the same thing as the condition in
the rat.
Dr. Robin: The gill does not appear
to respond by an increased Tm.
That is to say, the difference between the mixed venous and arterial bicarbonate concentrations
multiplied by cardiac output does
not increase under circumstances
in which plasma bicarbonate becomes markedly raised through inhalation of CO•. I would not want
to push these data too far, because
they are preliminary. It is much
more simple to measure Tm in a
dog kidney than in a dogfish gill,
but our impression is that this is
not a very sharply regulated mechanism; and I have no observations
of chronic changes.
Dr. Kiesow: In regard to your data
on the pond turtle, would you have,
by any chance, quotients on anaerobic glycolysis in various tissues, so
that one could get an idea about the
possible energy production by glycolytic pathways?
Dr. Robin: The RQ for the whole
animal rapidly approaches infinity.
He is producing C02 because of buffering of hydrogen ion by HCo.-,
and he is not using oxygen, so be
is producing buffer CO•. RQ measurements under these circumstances
are not useful for the whole animal.
We have some preliminary data for
brain slices, and our impression is
that, even under circumstances of
adequate oxygen supply, the preferential route of energy generation
is through anaerobic glycolysis.
Dr. Kiesow: Would you then say
that turtle tissues are pretty much
similar to cancer tissues?

Dr. Robin: This is a useful analogy.
They act like Ehrlich acites tumor
cells.
Dr. Kiesow: The fetal tissue, however, cannot survive under anaerobic conditions.
Dr. Robin: Nor can the turtle for,
say, longer than two weeks. I should
have made that clear. You are extending the three minutes of anoxic
survival in man, to two weeks in
the turtle, but he: a) runs out of
buffer, and that may be one factor;
and b) he may run out of substrate;
and c) he may have some absolute
oxygen requirement which produces structural deterioration after
a longer time.
Dr. Regelson: There is a lipid chemist who did a study of cardiolipin,
going on up through the animal
kingdom in an effort to determine
mitochondrial patterns and development of respiratory pathways in the
phylogenetic sense. He came across
a salamander, arnphiurna, which I
always wanted to work with and
which has no mitochondria at all.
There is deposition of a melanin
pigment and crystalloid aggregates
in the liver when amphiuma aestivates, the implication being that the
pigment in some way has a respiratory role. Several investigators
have postulated that melanin could
play a role in oxidation-reduction
systems to provide an alternative
source of energy.
Dr. Robin: That is very interesting.
I am not aware of that data.
Dr. Huf: In your earlier discussion
you emphasized the need for a low
Pco. and bicarbonate in aquatic
animals because they have to maintain their oxygen requirement. I
take it, then, that if one elevated
the C02 tension, the animal would
die because of interference with the
oxygen metabolism .
Dr. Robin: In the limiting case, yes.
If one is living on ambient oxygen
so that there is an ambient P0 2 of
150, there is a Pco2 so high that
the oxygen tension must be so correspondingly low that one cannot
survive.
Dr. Huf: Could one extrapolate
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from here and conclude that if one
infused animals with bicarbonate/
C02 mixtures at elevated Pco2 but
not in such a manner as would interfere with their general acid-base
balance, the animals could survive
if one also elevated the PO,?
Dr. Robin: This is under equilibrium circumstances, and all this relationship says is that, since nitrogen is fixed in an air-breathing
animal, in essence whatever is left
must be distributed between oxygen
and CO. in the steady-state circumstance. Hence, I do not think one
could extrapolate these quantitative
relationships therapeutically.
Dr. Brackett: The curve you showed
for chronic hypercapnia-between
40 and 60 mm Hg-showed a
normal pH. Certainly it is difficult
in clinical material to be sure about
associated acid-base disorders. I
assume that these were reasonably
excluded in your patients. On the
other hand, dog, as you pointed out,
never reaches "normal compensation," so this may be a semantic
problem, in part, but I would
wonder. We, too, have been interested in studying chronic, steadystate hypercapnia in carefully selected patients. If this same linear
relationship obtains and one knows,
in fact, the "normal pH" in an
individual, at any degree of
hypercapnia he would no~ have the
same hydrogen ion activity. I think
that, certainly above a Pco2 of 55,
there might be a discernible difference. Below that it is very difficult to know when paired data are
not available.
Dr. Robin: If one finds a range of
pH's, and one finds pH's as high
as 7.47 and 7.48, it would be hard
to believe that a patient, when he
was normal and his Pco2 was 40,
had a pH of 7.53 or 7.54. Secondly,
as was shown originally by Dr.
Schwartz, if one takes such patients and infuses bicarbonate so
that one normalizes arterial pH,
they promptly excrete the infused
HCO,-. That is to say, they return
to an extracellular pH which seems,
for whatever regulating mechanisms
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there are, to be satisfactory to them.
We have looked meticulously for
changes in chloride balance in some
of these patients to see what happens to exogenously administered
chloride and looked for evidence of
potassium depletion inside of muscle. While in some patients it is
possible to find some kind of complicating metabolic lesion, a number of these patients with normal
or elevated pH's do not show such
abnormalities. The implication of
the shark studies is that there is
another animal that is able to generate enough bicarbonate to maintain a baseline or a normal value
of pH in the face of sharp hypercapnia. Our extrapolation would be
that if it can occur in some animals,
then presumably it could occur in
man.
Dr. Brackett: The dog data do not
demonstrate complete compensation when starting with each individual dog's control pH, and in
our human data, on the basis of 20
patients and 40 steady-state points
carefully selected, man behaves
very much like the dog, with 95 %
significance bonds falling about two
nanomoles lower. This suggests that
man reaches for but never quite
attains complete compensation with
Pco2 's over 55 mm Hg.
Dr. Robin. Thank you. I think this
makes a very important point. In a
sense, it highlights the very real differences that exist in this area. People who are very much intrigued
with whole body titration curves
have been intrigued with statistical
analyses. It seems to me, though,
that if you are interested in mechanisms, it is more important to explain the exception, the man who
has the pH of 7.48 when his Pco2
is 55, because if you fit his values
in with statistics, it will just be a
point buried in the standard deviation of your whole body titration
curve. Yet it may mean that he has
hyperventilated, that he is potassium depleted or that he has special
kinds of regulatory mechanisms at
work. So, in a sense, I think both
approaches are important, but I like

to think, although this is a subjective judgment, that one of the ways
of progressing in this area is to
analyze these patients in a very individual, mechanistic sense. Of
course, the thing that impressed us
when we did this for intracellular
pH was the evidence that they regulated their intracellular pH more
closely than they regulated extracellular pH.

Intracellular pH Determination

by

Means of

pH Glass Microelectrodes*
I

NORMAN W. CARTER

Department of Internal Medicine, University of Texas Southwestern
Medical School, Dallas 75235

A number of years ago I decided
to attempt to measure the intracellular pH of skeletal muscle by a
more direct method than those in
current use, that is, by an electrode.
I excluded all forms of pH electrodes except the glass electrode
and then set up a certain number of
characteristics or requirements that
this electrode should have.
First, the electrode should be insulated in such a manner that only
the pH-sensitive portion is in the
cell cytoplasm. Second, the reference side of the electrode group
should also be within the cell, because the cell has a transmembrane
potential; and the only way to circumvent this transmembrane potential in actual electrical measurements is to have the reference
electrode within the cell. Finally,
the tip diameter of the combined
pH and reference electrode should
be less than 1 µ, in order to reduce
damage of the single cell by penetration or impalement.
Insulation of Electrodes

I soon discovered that one of the
major problems in constructing an
electrode was the method of insulating. My associates and I tried
a number of methods for obtaining
the required amount of insulation.
One method we developed at about
the same time as Kostyuk and Sorokina (1961) was the so-called con-

* Presented at the Symposium on
Intracellular pH, Pco, and PO,, September 29, 1967, Medical College of
Virginia, Richmond, Virginia.
MCV QUARTERLY 3(4): 197-205, 1967

centric capillary method in which
the pH capillary is run down a lead
glass shield. This method has certain deficiencies. First, the insulated
portion of the lead glass shield is
too thick to enter the cell, so that
one can never be sure that some
pH sensitive glass is not on the outside of the cell membrane. Second,
the numerous organic materials we
tried as sealants between the pH
glass and the lead glass imbibed
solution and ultimately lost their
high specific resistance. In addition,
although listed as industrial adhesives, many of these materials do
not adhere well to very small glass
capillaries. These organic materials,
then, although usually very satisfactory for electrical insulation, are
not very satisfactory for the electrodes used in the concentric capillary method. For these reasons,
none of the organic coverings were
found useful as insulating materials.
Our first successful insulating
technique, which was first reported
in 1961, was the use of a glass
stain (Carter). Of the several methods of staining glass, we chose the
silver glass stain, which is a good
method for insulation unless one
wants to make a large number of
electrodes. It has been known for a
long time that, if one takes a silver
salt and lays it on glass and then
brings the glass to a temperature
close to its annealing point, some
of the alkaline cations within the
glass will exchange with the silver
ions. Furthermore, the silver ions
that enter the glass will nucleate
or form a colloidal suspension.
Thus, in essence, what this glass

stain does is reduce the sens11Jv1ty
of the glass to hydrogen ion. Theoretically it is a good method, but
it is not a very practical one.
The final method we tried is the
one we are currently using and
have been using for a number of
years. This consists of covering the
pH glass with a glaze or fired-on
enamel. The principal drawback
with this wethod is that one has to
find a glaze or enamel that very
closely matches the thermal characteristics of the pH glass. Furthermore, this glaze, which is really
glass after being fused, has to have
high chemical resistance so that it
does not dissolve away from the pH
glass. We have developed a ceramic
glaze which we believe has the two
properties just mentioned, and it is
now commercially available. It is
a high titanium, low melting point,
lead glass. If one takes a small
capillary of pH glass and coats it
with this glaze, fires the glaze on
to the capillary and then pulls the
capillary out to a tapered tip, one
finds that, depending upon several
factors mentioned below, it is possible to pull out a small length of
pH-sensitive glass that has no glaze.
The length of this pH-sensitive tip
is determined by: 1) the initial
thickness of the glaze on the capillary; 2) the thickness of the wall
of the capillary or the diameter of
the capillary; 3) the ultimate length
of the overall taper. These factors
can be worked out empirically. For
example, it is possible not only to
select a capillary size that will allow
the tip to be pulled closed, but to
select a capillary size which, when
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coated with a certain thickness of
glaze, will result in a tip of pHsensitive glass that varies between
15 and 20 µ. in length. It is also
possible to add a small capillary of
lead glass parallel to the glazed pH
capillary and pull these capillaries
simultaneously so that a single tip
made up of two components will
result and the reference side of the
electrode will remain open. If the
glaze is applied correctly, the pH
side can be what we call "insulated"
down to within a few microns of
the tip. This is the ideal electrode.
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Testing of Electrodes
The electrode is placed in a Teflon holder which contains a silversilver chloride electrode and the
mechanical attachments for mounting it in a micromanipulator. With
this type of construction a number
of tests must be made before any
given electrode can be used to make
a biologic measurement. Figure 1
shows the results obtained from an
electrode which was checked in several buffers against its millivolt
reading. The electrode had a fairly
linear relationship over the range
from pH 4.0 to pH 10.0 and was
quite sensitive in the pH range in
which we were most interested. The
tips of these electrodes are extremely delicate, of course. Not all
types of pH glasses are very durable by present day standards. It is
not good practice to leave the electrodes in either pH 4.0 or pH 10.0
for any length of time, because they
will deteriorate. Contrary to what
had been previously published about
Corning 0150 pH glass, we found it
maintained its properties best, although not very well, in distilled
water. Therefore, once one obtains
a workable electrode, it is mandatory to perform all necessary tests
and then use it without delay. The
electrode depicted in Figure 1 had,
at 25°, a slope of 58.7 mv for a
tenfold change in H + activity. Most
of the electrodes have somewhat
smaller than theoretical slope factor.
We have selected electrodes that
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Fig. I- Voltage response of a double-barrelled micro pH electrode to various
buffer solutions. (Reprinted with permission from Federation Proc., 1967a.)

have slopes above 40 mv per pH
unit.
Electrodes are tested in several
ways. One is to check the electrode's
ability to correctly read pH of whole
blood measured with a Beckman
blood pH electrode. Another way
is to test the electrode in a muscle
homogenate by homogenizing muscle in as small an amount of water
as possible, measuring the pH with
a microelectrode and comparing
the vesults with those of the pH
electrode. What we are looking for,
principally, is not a real fault of
the glass membrane, i.e., its "protein error." A s a matter of fact, we
believe it is possible to reduce the
so-called protein error to nearly
zero by lightly siliconizing the surface of the microtips. What we are
interested in is what the various
micromolecules, and particularly
the various anions, do to the tip
potential of the reference side of
the electrode. An electrode which
otherwise seems to be a very good
pH electrode may, because of its

reference electrode, be worthless in
a biologic solution. For example,
the Beckman electrode may read
pH 7.4, whereas the reference side,
for reasons unknown, may give an
apparent pH of 9.0. When you put
the electrode into the muscle homogenate, it may pick up a new tip
potential of perhaps 40 or 50 mv,
which it never loses. The electrode,
then, has to be discarded.
The tip potential of the reference
side is generally quite low, and, as
you will see later, we bucked the
tip potential to where we wanted it
to be and kept checking to make
certain that it had not shifted. There
are electrodes that go through all
the checks and seem to be good electrodes until one starts making muscle punctures. Then the slope of the
pH side of the electrode or the tip
potential of the reference side
changes tremendously. When this
happens, the electrode usually is
not recoverable. There is no consistent direction in which bad electrodes change. Providing there is
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no mechanical injury to the electrode, the operational life of a truly
good electrode varies somewhere
between several hours to three
weeks.
As I indicated earlier, insulation
is one of the most important aspects of the entire operation of
building and using microelectrodes,
and for a long time we did not
have an in vitro method of testing
insulation. Several years ago we developed a method of testing insulation which , because it entailed micropuncture and perfusion of the
rat kidney tubule, would never have
gained acceptance. (Rector, Carter
and Seldin, 1965) If one is fairly
adept at perfusion in single tubules
and puncturing the tubule, this is
a satisfactory way of checking the
insulation of electrodes. Finally, an
in vitro method was developed. We
found it possible to make a membrane out of the latex used in comparative anatomy laboratories for
injecting cats. The latex was poured
on a piece of paraffin® film that
had a hole cut in it. We obtained
a membrane about 1 p, thick that
sealed around the microtip well
enough to prevent the buffer running down between the membrane
and into a buffered agar below the
membrane. We used agar in the
lower buffer to give mechanical
strength to the membrane. It was
possible by direct microscopic observation to measure how far the
microtip had penetrated the membrane into the agar. It was therefore
possible to determine how much of
the electrode tip was pH sensitive.
Table 1 shows the use of both
insulated and uninsulated electrodes
in the latex membrane method.
When tested in buffered solutions
of pH 6.0 and pH 7.4, these electrodes both read pH reasonably
well. One had a slope of 58 mv;
the other, 55 nw. These measurements were made at room temperature. When the insulated electrode
was placed so that its tip was 10 p,
below the latex, and, thus, inserted into the pH 6.0 buffered agar,
it gave approximately the same

TABLE 1
In vitro test of double-barrelled microelectrodes

Insulated Electrode
Apparent
Depth of Electrometer pH of
Agar
Penetra- Reading
Buffer
mv
tion µ
Buffer pH 6.0
Buffer pH 7.4
Agar Buffer
pH 6.0
Overlaid Buffer
pH 7.4
Transmembrane
Potential of
90 mv Imposed

+157}
+ 76

Uninsulated Electrode
Apparent
Depth of Electrometer pH of
Penetra- Reading
Agar
tion µ
mv
Buffer
+155}

58 mv / pH
unit

+ 78

55 mv / pH
unit

10

+155

6.04

42

+ 157

5.96

10

+155

6.04

42

+ 86

7.24

10

+ 155

6.04

42

+ 101

6.97

Reprinted with permission from J. Clin. Invest., 1967b.
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Fig. 2-Method for measuring intracellular pH and transmembrane potential
simultaneously with a double-barrelled electrode. (Reprinted with permission
from J. Clin. Invest., 1967b.)
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reading as it did when tested previously in a solution of pH 6.0
buffer. When we overlaid with pH
7.4 buffer on the upper surface of
the latex membrane, there was no
change in the electrometer reading;
and the apparent pH still stood at
approximatel y pH 6.0 . Finally,
when we imposed the 90 mv synthetic membrane potential, there
was no effect whatsoever on the
electrometer reading.
In the case of the uninsulated
electrode, the tip penetrated 42 µ,
an inordinate distance. Even with
42 µ below the surface of the latex
membrane, however, we got an apparent pH change when we overlaid pH 7.4 buffer, which suggested
that there was a significant amount
of uninsulated pH glass above the
membrane, or above the 42 µpoint .
Finally, when we imposed the
90 mv transmembrane potential,
we obtained a further change in the
pH reading. Each electrode has to
go through this test. Although this
test is not technically difficult, it
requires a large number of manipulations. One usually breaks the
electrode at this point and has to
make a new start.

utilizing the shunt circuit on the
input of the electrometer, we were
able to measure at will the resistance of both the reference and pH
sides of the electrode even while
they were inside of a muscle cell.
It was possible by this means to
ascertain whether we were dealing
with an intact electrode or one that
had been accidentally broken off by
impalement. (Carter et al., 1967b)
In Table 2 we show data obtained in normal rats. Most scientists who study transmembrane
potentials consider the highest transmembrane potential to be the correct one. Hence, we arbitrarily took
a value of 89 mv plus or minus

TABLE 2
Intracellular pH of Normal Rat Skeletal Muscle

200

Number of
Measurements

Range

7
38
38

7.38-7.44
85-92 mv
5.77- 6.29

Blood pH
Transmembrane Potential
Intracellular pH

Mean ± S.D.
7.41 ± 0.06
88.7 ± 2.2 mv
5.99 ± 0.14

Reprinted with permission from Federation Proc., 1967a.

Intracellular pH and
Transmembrane Potential

With the use of these doublebarrelled electrodes and two electrometers, one can simultaneously
make readings of intracellular pH
and record transmembrane potential. Figure 2 shows how this is
done, namely, by connecting the
reference side of the microelectrode
to both an independent electrometer and the low impedance side of
a pH electrometer.
During a series of measurements
we removed the electrode and rechecked it by dipping the electrode
in our test solutions to determine
not only whether the electrode was
still reading the same pH as previously in any given buffer, but
whether the reference of the pH
electrode has developed any significant change in tip potential. By

one standard deviation, which was
3 mv, a value that we obtained
from almost 300 impalements in
24 rats, using Ling electrodes to
measure normal transmembrane potential. We examined those pH
measurements that fell within the
emf range from 86 to 92 mv. In
this range we had 38 measurements
from seven rats. The blood pH of
the rats was 7.41. The average potential of these 38 readings was
88.7 mv, which was close to the
88.9 mv potential previously found.
The mean intracellular pH was
5.99. If this result means that hydrogen ions are in electrochemical
equilibrium across the skeletal mus-
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Fig. 3-Measured intracellular pH of rat skeletal muscle (with a simultaneous
Em measurement of -85mv or higher) with electrodes having various lengths
of pH-sensitive tips. (Reprinted with permission from J. Clin. Invest., 1967b.)
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cle membrane, then we should be
able to determine mathematically
the accuracy of our method.
If there is electrochemical equilibrium between blood pH and intracellular pH, then these results
should fit the Nernst equation:
Em = 61.5 (pH blood - pH,),
where Em is the transmembrane
potential in mv and pH, intracellular
pH. If the observed Em ( - 88. 7
mv) and blood pH (7.41) are used,
the calculated pH , is 5.97, which is
very close to the observed value of
5.99, strongly suggesting electrochemical equilibrium for H +
activity.
In Figure 3 one sees the results
of a group of experiments which
show the importance of insulation
and its relationship to intracellular
pH. Originally this work was deliberately undertaken with poorly
insulated electrodes because of the
findings of Dr. Peter Caldwell from
Bristol, England, and Kostyuk and
Sorokina in Russia. We now feel
it was not poor insulation that affected the data obtained by Dr.
Caldwell (1958). The only reason
we believe the Russian workers'
electrodes were poorly insulated is
that they used as insulators organic
materials which we have never
found satisfactory. Both Caldwell
in his work with the crab muscle,
and Kostyuk and Sorokina with the
frog muscle have shown by their
electrode methods that there is no
electrochemical equilibrium between extracellular and intracellular
compartments for H+. This figure shows that, if insulation is less
than adequate, one will obtain a
reading for intracellular pH that
increases steadily until the length
of the exposed tip is about 50 µ,.
From that point on the values will
mostly fall around a pH of 7.0.

Single-Barrelled pH Electrodes
Despite the fact that we are getting very small tip diameters with
our double-barrelled electrodes, it
was thought necessary to use a
single-barrelled pH electrode which

can be pulled to a tip diameter well
under .5 µ , thus reducing the possibility of cell damage by impalement. If one had a pH electrode
outside the cell in the extracellular
fluid, read its potential against a
reference electrode in this fluid, and
set this potential to zero, there
would be no potential change when
the cell membrane was impaled if
H+ were in electrochemical equilibrium. The reason for this is that

the potential across the membrane
would exactly balance the reading
obtained from the pH electrode because of the change in H + activity
inside. This only holds for electrodes that have a theoretic slope
of 61.5 mv at 37C. If the slope is
less than theoretic, one reads a potential greater than zero, but this
potential can be calculated.
In Figure 4 we show the predicted potential difference that we
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would expect to get with the varying electrode slopes. We have drawn
in the line that should be generated
at various slopes with hydrogen ion
equilibrium at an intracellular pH
of about 5.95. The top line is what
we would expect with non-equilibrium at an intracellular pH of 7 .0
and different electrode slopes. We
made the impalements and measured the potential. It is fairly clear
that the points are clustering about
the lower line. Certainly none of
them are near the upper line. Hence,
the data obtained with the singlebarrelled electrode is in agreement
with that obtained with the doublebarrelled electrode; namely, H + appears to be in electrochemical equilibrium across the cell membrane.
Triple-Barrelled pH Electrodes

In Figure 5 we show the results
of a single experiment made with
a triple-barrelled electrode. In this
electrode a third barrel was placed
parallel to the other two, and the
third barrel was used to impose a
current across the muscle cell mem-

brane. In other words, we applied
electric current to alter the transmembrane potential and observed
simultaneously changes in measured
intracellular pH. We varied the
transmembrane potential, at least
in the area of the tip of the
reference electrode, from a value
of about +20 mv to -240 mv.
The actual pH measurements we
obtained at these various membrane potentials appear to fall more
closely along what we call membrane slope, referring to the muscle
cell, than along the electrode slope
(the dotted line) . We conducted
five of these experiments with five
different electrodes. Results were
similar to those in Figure 5.
The results with these triple-barrelled electrode experiments further
suggest that H + across the skeletal
muscle cell membrane is in electrochemical equilibrium.
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Dr. Robin: Some biologists claim
that they have data which show that
the hydrogen ions move very slowly
into cells. It would seem to me that
a simple way of testing your interpretation would be to administer
hydrogen ions in the form of hydrogen chloride and show that hydrogen ions are in electrochemical
equilibrium.
Dr. Carter: Yes. We've done this
with hydrogen chloride, and also by
producing respiratory acidosis and
respiratory alkalosis. From intracellular pH measurements with the
the pH electrode, it appears that
hydrogen ions are in electrochemical equilibrium.
Dr. Jobsis: I remember that Con-
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way, defending himself against
criticism raised by A. V. Hill, made
some calculations on the speed of
hydrogen ion movement into muscle. He came to the conclusion that
these ions move only very slowly.
Dr. Carter: In his calculations,
Conway made the rather arbitrary
assumption that the mobility of
hydrogen ion potassium in solution
was the same. It turned out that it
would take about 360 days to bring
about one-half of a pH change in
skeletal muscle. Nevertheless, many
people hold to the view that hydrogen ions move very slowly, and they
base their argument principally on
the observation that Dr. Robin
wanted us to look at, i.e., that
metabolic acidosis does not seem
to change the intracellular pH as
measured by other than the pH
electrode techniques.
Dr. Robin: Dr. Carter's work is
obviously technically magnificent,
and he has been put in the unfortunate position of being attacked
from all sides because the methods
that he uses are so advanced and
technically so difficult. It is, therefore, hard to find experimenters
who are capable of either confirming or denying his results. There
are, however, other methods for
measuring intracellular pH. I would
like to mention three results obtained by independent methods
which would be very difficult to
reconcile with Dr. Carter's results,
but are in good agreement with
results obtained by indicator systems. I am not mentioning these
findings to indicate that I think that
they resolve the question. Firstly, if
one assumes that the intracellular
pH in the muscle is 5.95 to 6.00,
then one can calculate the total
amount of CO. which is present in
the muscle; obviously, this would be
very small in amount. If one uses
the intracellular pH of 6.9 as obtained by indicator methods, then
the amount of CO. which is in the
body is considerably larger. One
can measure CO. stores by independent methods, essentially dilution methods, that have nothing to

do with the measurement of intracellular pH. Thus, one finds experimentally for the total body CO. a
value which is much closer to the
one predicted by calculation, assuming a value of 7, rather than 6,
for intracellular pH. There is, however, the unresolved question
whether a part of the CO. is present in the body as the "barium
soluble" form. Secondly, in view of
the difficulty just mentioned,
another technique for measuring
CO. stores has been used, which is
as follows . The animal or human
increases or decreases his C02
stores by hypo- or hyperventilation,
and under these circumstances, by
observing the amount of C02 which
has been added to or subtracted
from the body, one can estimate
the C02 stores. If this calculated
value for whole body C02 is compared with the value obtained by
application of the DMO technique,
or the H.CO.-bicarbonate indicator
technique, the results are in good
agreement. On the other hand, if
one makes use of an intracellular
pH value of 5.99 or 6.00, the results are quite disparate. This would
mean either that the value of 5.9
for intracellular pH in muscle is
low, or that all the CO. which has
been added to the body was instantly converted into the barium
soluble form . This is a rather unlikely possibility. Thirdly, if one
administers mineral acid or base to
an animal and then measures total
CO, in muscle by gasometric procedures which are independent of
any assumption about how that CO.
is compartmentalized between dissolved CO., carbonic acid and bicarbonate, one can show that there
is no evidence in terms of total
CO. that the muscle is being titrated
either by hydrogen ion or by bicarbonate. This leaves one in the
rather uncomfortable position, accepting a pH value of 6.0, of saying that the gasometric techniques,
which, as I emphasized, are independent of any assumptions about
C02 compartmentalization, are fortuitously making precisely the same

errors as are being made by measurements with pH indicators. That's
not a question; that is a comment.
Dr. Carter: Unfortunately, one
comment deserves another. We do
not have time to go into our experiments with DMO, but suffice it
to say that we think, as probably
some of you have heard, that DMO
is bound intracellularly. And although I have no data on the subject that is worth reporting here, it
would appear that bicarbonate and
DMO are located in the same
space; perhaps one replaces the
other. I'm not sure that this would
explain all of the observations
which you mentioned. But if allowance is made for some peculiar
site, I think that the data could be
reconciled on this basis. I have
great reservations about the idea of
the acid-labile CO,, as put forth
by Conway, for a variety of reasons.
I don't think that new bicarbonate is formed either when the
muscle is treated with potassium hydroxide for a short period of time,
or when it is released with strong
acid. I rather believe that some of
the bicarbonate is not measured in
the compartment that we call the
bulk phase of the cell where we are
getting the pH of 6. I don't think
that negates the fact that there may
be some other place where it is
definitely measured and where,
under a variety of physiologic alterations, it is purposefully utilized.
I would agree with you that this is
the meat of the whole issue. One
might even go further and clarify
it in very definite terms. At the current time there are almost 400 publications on intracellular pH utilizing either DMO or bicarbonate
partition. With one exception, all
of these agree in principle that the
pH is near 7. It may vary from pH
6.7 to 7 .2, but that is near pH 7.
No one agrees with us that it is
near pH 6, with one exception. We
do have a problem indeed, but I
can only show the data that we
have. We are aware of the problem
and anxious to reconcile the conflicting results.
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Dr. Ramsey: Dr. Carter, is that one
exception Fenn and Maurer?
Dr. Carter: Conway and Fearon
(J. Physiol. (London) 103: 274
289, 1944).
Dr. Ramsey: I thought that around
1935 Fenn and Maurer, using the
bicarbonate method, found that
muscle had a pH around 6.
Dr. Carter: I know Fenn's various
methods for measuring bicarbonate.
I was not aware of the fact that he
had a value of pH 6. He has several
values of pH 7. Now he may well
have one of 6, but he has several
of 7. The only other pH measurement which agrees with our data is
the one published by Netter, who
used ammonia. I am inclined, however, to disregard his data, as I do
Conway's result. Netter's data are
quoted by Peter Caldwell in his
review, and he gives a value of pH
7. However, if one looks at the
original article, one finds. out that
the 7 value is arrived at by making
certain chemical assumptions which
may or may not be true. The absolute method of partition gives a
value closer to 5.6, which is of
some interest, particularly in regard to pK's of indicators. I think
there are too many complications
with ammonia, e.g., its binding,
production, etc., applied . to the
whole cell; ammonia does not give
a valid measurement.
Dr. Robin: There is hope with an
ammonia technique different from
the one that Netter used. One can
load the animal with sufficient exogenous ammonia to swamp out
endogenous ammonia. This would
be critical, because if the indicator
methods using negatively charged
species give falsely high values because of heterogeneity within the
cell, then positively charged species
would be expected to give falsely
low values. We have tested this in
one system, the red cell. This is a
bad one to use, because it is easy to
measure pH in the red cell by any
technique, and one can easily agree
that it is in electrochemical equilibrium. By using the swamping-out
technique, one can arrive at intra204

cellular pH's measured in the red
cell by the ammonia technique, by
the DMO technique, by the CO,
technique, if one corrects for carbamino CO,, by chloride ratios and
freeze-thaw, which are not significantly different.
Dr. Carter: We have given the
swamping-out technique some
thought. The trouble with its application to the whole animal is
that we got into much difficulty
with what we assume are effects of
ammonium ion, particularly on the
central nervous system. I am not
sure of this, but, anyway, it is difficult to apply this technique. We
probably came nowhere near a
condition of swamping-out. Let me
hasten to say that as far as the red
cell is concerned, we would very
much like to put the pH electrode
into the red cell, in the absence of
DMO, and see whether the pH is
the same as the rather good pH
values obtained with the other
methods.
Dr. Robin: Let me caution you before you start, although you are
much more skilled at puncturing
red cells than we are. We have
spent four years getting to the point
where we can insert an electrode
for measuring transmembrane potential. About 15 to 20 seconds
after insertion of the electrode, the
cells disrupt. Furthermore, baseline stability is reached very quickly.
If you decide to try red cells, I
suggest using the red cell of the
bullfrog, because this cell is much
larger and wider than the human.
For two years we have also tried to
use red cells of amphiuma or cryptobranchus. They are very big (90
µ,, but they have a very thin membrane, and there is no way at
all of preserving the transmembrane potential.
Dr. Carter: Yes. Could you measure the transmembrane potential?
Dr. Robin: We believe we have
obtained some useful preliminary
measurements which agree with
chloride distribution.
Dr. Carter: It would be nice if we
could insert the pH electrode into

these cells. In a circumstantial sort
of way, that would be at least one
area for agreement, hopefully. On
the other hand, if we obtained
different measurements, we would
really be in trouble.
Dr. Huf: I want to take one step
back. I am not sure, but I think the
problem is still more complex. I
am speaking here about the transmembrane potential. The question
is: What is the source of the potential? Speaking about muscle and
biological membranes in general,
I am surprised that you haven't
considered the possibility that there
is a sodium pump effect. We begin
to realize more and more that the
membrane potential is generated by
an electrogenic sodium pump.
Other ions are distributed in accordance with the laws of thermodynamics. If one looks at the rate
at which changes in the passive distribution of ions occurs, it seems to
me that this would also depend on
the rate at which the driving force,
the sodium pump potential, changes.
Alkalosis and acidosis are known
to change the rate of active sodium
transport. So maybe this is a determining factor, and my question
is : Has this been considered?
Dr. Carter: It has, yes. I was not
going to go into that in any great
detail, because of time limitation.
Certainly, as you state, currently
there are m any people who believe that the membrane potential
arises from an electrogenic pump,
pumping sodium out of the cell. It
is certainly conceivable that
changes in external pH would affect the pump. That should also
affect the potential. Now I realize
that there have been some people
who claimed that not all of the
electrogenic status is seen in the
transmembrane potential, and I
suppose that is a loophole. Stimulated by the ideas of Hodgkin and
his workers on the origin of the
transmembrane potential under
steady-state conditions, we became
interested in observing changes in
transmembrane potential in experiments where we control potassium,
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principally. This, certainly, is an
oversimplification, but I also think
that it is a point of departure.
Electrogenic pumps are a convenient answer to the problem, but I
also think that some of these socalled electrogenic pumps, have
arisen because investigators have
found strange results on the ratios
of various ions across the membrane. Finally, let me say that there
may be yet a third mechanism for
the production of the potential. It
is conceivable that hydrogen ion
sets the potential.
Dr. Huf: Then you should not be
in agreement with the Nernst equation if this is the case.
Dr. Carter: Yes, why not? If you
say potassium sets the potential,
you are practically in agreement,
and we are practically in agreement
with hydrogen ion.
Dr. Huf: What I am driving at is
this: Do you think that hydrogen
ions are actively transported?
Dr. Carter: I know what you mean.
No. I do not think this. I am saying this is another possibility, and
you are absolutely right. If it is in
absolute equilibrium, you do not
have the potential, but looking at
the case of potassium, hydrogen
may behave exactly like the potassium.
Dr. Robin: There are various mechanisms for the development of
transmembrane potential in biological systems. One of them is a
Donnan distribution, which applies,
for example, in the red cell. Here,
with macromolecules present on
the inside of the red cell, chloride
distributes itself unequally, and
under these circumstances, a potential difference arises.. It has
nothing to do with the sodium or
potassium pump, either theoretically or actually. That is to say,
one can stop the sodium or potassium pumping mechanisms, or
change the sodium or potassium
concentrations of the outside media,
and this has no effect whatsoever
on the distribution of chloride
ratios or on the transmembrane
potential.

Dr. Huf: All I am saying is that,
if a pump is in operation, this
pump, in effect, takes the place of
a Donnan system.
Dr. Robin: Well, that depends on
the relative mobility of the ions involved. Again, in the case of the
red cell, where, presumably, chloride ions reach the thermodynamic
equilibrium in microseconds-remember the half time for sodium
is three weeks-one can modify
the operation of the sodium pump
to any extent, but it will not affect
the transmembrane potential. Is it
not true that, since potassium is in
electrochemical equilibrium across
the muscle, this suggested to Hodgkin that it wasn't a diffusion pump
that was responsible for this distribution ratio?
Dr. Huf: Ion mobilities are important, but so is the driving force ,
the pump potential.
Dr. Kiesow: Dr. Carter, is it correct that, by altering the membrane
potential, you can change the intracellular pH, assuming that there
is an electrochemical equilibrium?
Dr. Carter: This is true if it is done
by means of an electrode. Remember that, under those circumstances,
the required anion or cation is supplied by the current-generating
electrode. We were trying to look
into this for more physiological
conditions.
Dr. Kiesow: Since the pH changes
are quite drastic ones, I would
suggest using a physiological, intracellular pH indicator, which is
already present and which can
easily be observed-even in intact
cells and tissues-by means of
spectrophotometry. This is the
[DPN.H] X [H'] : [DPN] ratio and
its response to such an intracellular
pH change. Since it is a change in
ion activity of at least an order of
magnitude, it should affect this
ratio considerably.
Dr. Carter: Yes, it is. That should
follow, I would think. The only exception is that the part that you can
measure might be principally located in the mitochondria, as I
understand it. Of course, nothing

that we have said necessarily has
anything to do with mitochondrial
pH.
Dr. Kiesow: You could very well
also measure the cytoplasmic concentration of reduced pyridine
nucleotides.
Dr. Carter: Is there enough to see,
technically?
Dr. Jobsis: Yes, fiuorometrically
you are better off. You can see the
mitochondrial part, but in spectrophotometry you see both equally.
Dr. Carter: You can alter the membrane potential by a drastic amount,
and this does indeed seem to alter
the pH that we are measuring. Under those circumstances I would
think this would be possible. These
have to be quite rapid measurements.
Dr. Kiesow: Oh, this should not be
a problem here.
Dr. Carter: This is not a very stable
situation.
Dr. Kiesow: Even if it is only
transient, these optical or fiuorometric methods are very rapid.
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when stress results in
muscle strain and pain
When the normally sedentary person suddenly turns
active-cleaning the attic, for instance-the outcome
is sometimes a strain or sprain in the back, neck or
shoulders.
Fortunately, however, most patients with muscle
spasm and pain are highly responsive to therapy
with Robaxisal. This rationally based formula provides the well-known relaxant benefits of methocarbamol for strained, tense skeletal muscle plus the
dependable analgesic and anti-inflammatory effects
of aspirin. Investigators have found methocarbamol
a well-tolerated agent with "specificity of action.m
And methocarbamol potentiates the salicylate levels
of aspirin so that, in combination/ higher salicylate
levels are produced than with equivalent doses of
aspirin alone. 2 When the Robaxisal combination*
was administered to a group of 22 patieRts with
painful musculoskeletal disorders, 20 (91 per cent)
showed an excellent or good response. 2
With Robaxisal you can conveniently fulfill the most
important objectives in treatment of muscle spasm:
relaxation of skeletal muscle, relief of pain, restoration of mobility and normal muscle tone. And when
mild anxiety is a factor in the spasm-pain syndrome,
consider Robaxisal®-PH.
*In this investigation, 400 mg. methocarbamol was comb ined with 300 mg. aspirin.
Refer ences : 1. Weiss, M., and Weiss, S. : J. Am. Osteopa th. A. 62:142, 1962. 2. Truitt,
E.B ., Jr.; Morgan, A.M., and Nachma n , H.M.; South. M.J. 54:318, 1961.

B~baxisal®brings relief
Each pink and white laminated tablet contains:
Robaxin (methocarbamol, Robins) ... .... . .... 400 mg.
U. S. Pat. No. 2770649
Aspiri n (5 gr.) ......... . . ............... , .. 325 mg.
Robaxisal$-PH
Each green and white laminated tablet contains:
Robaxin (metho carbamo l, Robins) ............ 400 mg.
Phenace tin . ...... ... . ........ . .... .. .... ... . 97 mg.
Aspirin .. ........... . ... .. ................ • . 81 mg.
Ph enoba rbital (1 /8 gr.) .... . ....... ...... . . .. 8.1 mg.
(Warning: May be habit forming)
Hy oscyamine sulfate ... .. ... . . . ..... . ..... 0.016 mg.
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A . H. ROBINS COMPAN Y, INC.
RICHMOND. VIRGINIA 23220
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Robaxisal and Robaxisal-PH are indicated when both analgesic and
skeletal mu scle relaxant effec ts are req uired, as in st rains and· sprains,
painful disorders of the back, "whiplash" injury, myositis, pain and
spasm associa ted with arthritis, torticollis, and h eadache associated
with mu scular tension.
Contraindications: Hypersensitivity to any one of the components.
Side Effects: Lightheadedness, sl igh t drowsiness, dizzi n ess, and nau sea
may occur rarely in patien ts with unu sual sensi tivity to drugs, but
usually disappear on reduction of dosage.

WHEN ANXIETY
IS A SIGNIFICANT
COMPONENT OF THE
CLINICAL PROFILE

LIBRIUM®

(chlordiazepoxide HCI)
Also available as
LIBRITABST.M. (chlordiazepoxide)
5-mg, 10-mg, 25-mg tablets

Before prescribing, please consult complete product information, a summary of which follows:
Contraindications: Patients with known hypersensitivity to the drug.
Warnings: Caution patients about possible combined effects with alcohol and other CNS depressants. As with all

CNS-acting drugs, caution patients against hazardous occupations requiring complete mental alertness (e.g.,
operating machinery, driving). Though physical and psychological dependence have rarely been reported on
recommended doses, use caution in administering to addiction-prone individuals or those who might increase
dosage; withdrawal symptoms (including convulsions), following discontinuation of the drug and similar to
those .seen with barbiturates, have been reported . Use of any drug in pregnancy, lactation, or in women of child: bearing age requires that its potential benefits be weighed against its possible hazards.
Precautions: In the elderly and debilitated, and in children over six, limit to smallest effective dosage (initially
10 mg or less per day) to preclude ataxia or oversedation, increasing gradually as needed and tolerated. Not
recommended in children under six. Though generally not recommended, if combination therapy with other
psychotropics seems indicated, carefully consider individual pharmacologic effects, particularly in use of
potentiating drugs such as MAO inhibitors and phenothiazines. Observe usual precautions in presence of impaired renal or hepatic function. Paradoxical reactions (e.g., excitement, stimulation and acute rage) have been
reported in psychiatric patients and hyperactive aggressive children. Employ usual precautions in treatment of
anxiety states with evidence of impending depression; suicidal tendencies may be present and p~otective measures necessary. Variable effects on blood coagulation have been reported very rarely in patients receiving the
drug and oral anticoagulants; causal relationship has not been established clinically.
·
Adverse Reactions: Drowsiness, ataxia and confusion may occur, especially in the elderly and debilitated. These
are reversible in most instances by proper dosage adjustment, but are also occasionally observed at the lower
dosage ranges. In a few instances syncope has been reported. Also encountered are isolated instances of skin
eruptions, edema, minor menstrual i rregularities, nausea and constipation, extrapyramidal symptoms, increased and decreased libido-all infrequent and generally controlled with dosage reduction; changes in EEG
patterns (low-voltage fast activity) may appear during and after treatment; blood dyscrasias (including agranulocytosis), jaundice and hepatic dysfunction have been reported occasionally, making periodic blood counts
and liver-function tests advisable during protracted therapy.
Usual Daily Dosage: Individualize for maximum beneficial effects. Oral-Adults: Mild and moderate anxiety and
tension, 5 or 10 mg t.i .d. or q.i.d.; severe states, 20 or 25 mg t.i.d. or q.i.d. Geriatric patients: 5 mg b.i.d. to
q .i.d. (See Precautions.)
Supplied: Librium® (chlordiazepoxide HCI) Capsules, 5 mg, 10 mg and 25 mg-bottles of 50. Libritabsr·"· (chlordiazepoxide) Tablets, 5 mg, 10 mg and 25 mg - bottles of 100. With respect to clinical activity, capsules and
tablets are indistinguishable.
Roche Laboratories • Division of Hoffmann-La Roche Inc• Nutley, N.J. 07110

